WO2001066773A2 - Nucleic acids that code for oxidosqualene cyclases - Google Patents
Nucleic acids that code for oxidosqualene cyclases Download PDFInfo
- Publication number
- WO2001066773A2 WO2001066773A2 PCT/US2001/007611 US0107611W WO0166773A2 WO 2001066773 A2 WO2001066773 A2 WO 2001066773A2 US 0107611 W US0107611 W US 0107611W WO 0166773 A2 WO0166773 A2 WO 0166773A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- plant
- polynucleotide
- cell
- isolated
- seq
- Prior art date
Links
- 150000007523 nucleic acids Chemical class 0.000 title claims abstract description 84
- 108010059597 Lanosterol synthase Proteins 0.000 title claims abstract description 60
- 102000039446 nucleic acids Human genes 0.000 title description 13
- 108020004707 nucleic acids Proteins 0.000 title description 13
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 124
- 108091033319 polynucleotide Proteins 0.000 claims abstract description 75
- 102000040430 polynucleotide Human genes 0.000 claims abstract description 75
- 239000002157 polynucleotide Substances 0.000 claims abstract description 75
- 230000001105 regulatory effect Effects 0.000 claims abstract description 18
- 241000196324 Embryophyta Species 0.000 claims description 122
- 210000004027 cell Anatomy 0.000 claims description 103
- 239000002773 nucleotide Substances 0.000 claims description 77
- 125000003729 nucleotide group Chemical group 0.000 claims description 77
- 238000000034 method Methods 0.000 claims description 68
- 235000010469 Glycine max Nutrition 0.000 claims description 57
- 150000001413 amino acids Chemical class 0.000 claims description 56
- 230000014509 gene expression Effects 0.000 claims description 52
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 47
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 47
- 244000068988 Glycine max Species 0.000 claims description 45
- 229920001184 polypeptide Polymers 0.000 claims description 42
- 108020004414 DNA Proteins 0.000 claims description 37
- 239000000047 product Substances 0.000 claims description 34
- 108091028043 Nucleic acid sequence Proteins 0.000 claims description 28
- 108010064634 2,3-oxidosqualene-beta-amyrin-cyclase Proteins 0.000 claims description 25
- 108010073771 Soybean Proteins Proteins 0.000 claims description 25
- 229940001941 soy protein Drugs 0.000 claims description 25
- 229930182490 saponin Natural products 0.000 claims description 22
- 150000007949 saponins Chemical class 0.000 claims description 22
- 235000017709 saponins Nutrition 0.000 claims description 22
- 108091032973 (ribonucleotides)n+m Proteins 0.000 claims description 19
- 235000013305 food Nutrition 0.000 claims description 18
- 150000003648 triterpenes Chemical class 0.000 claims description 18
- JFSHUTJDVKUMTJ-QHPUVITPSA-N beta-amyrin Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C JFSHUTJDVKUMTJ-QHPUVITPSA-N 0.000 claims description 16
- FSLPMRQHCOLESF-UHFFFAOYSA-N alpha-amyrenol Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C)CCC(C)C(C)C5C4=CCC3C21C FSLPMRQHCOLESF-UHFFFAOYSA-N 0.000 claims description 15
- QQFMRPIKDLHLKB-UHFFFAOYSA-N beta-amyrin Natural products CC1C2C3=CCC4C5(C)CCC(O)C(C)(C)C5CCC4(C)C3(C)CCC2(C)CCC1(C)C QQFMRPIKDLHLKB-UHFFFAOYSA-N 0.000 claims description 15
- PDNLMONKODEGSE-UHFFFAOYSA-N beta-amyrin acetate Natural products CC(=O)OC1CCC2(C)C(CCC3(C)C4(C)CCC5(C)CCC(C)(C)CC5C4=CCC23C)C1(C)C PDNLMONKODEGSE-UHFFFAOYSA-N 0.000 claims description 15
- 238000004519 manufacturing process Methods 0.000 claims description 13
- 102000004190 Enzymes Human genes 0.000 claims description 12
- 108090000790 Enzymes Proteins 0.000 claims description 12
- 230000000295 complement effect Effects 0.000 claims description 12
- 244000098338 Triticum aestivum Species 0.000 claims description 11
- 240000008042 Zea mays Species 0.000 claims description 11
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims description 11
- 235000013339 cereals Nutrition 0.000 claims description 11
- 235000021307 Triticum Nutrition 0.000 claims description 10
- 235000013372 meat Nutrition 0.000 claims description 10
- 230000009261 transgenic effect Effects 0.000 claims description 10
- 238000012545 processing Methods 0.000 claims description 9
- 239000012141 concentrate Substances 0.000 claims description 8
- 239000000203 mixture Substances 0.000 claims description 8
- 235000014571 nuts Nutrition 0.000 claims description 8
- 239000001397 quillaja saponaria molina bark Substances 0.000 claims description 8
- 241000209510 Liliopsida Species 0.000 claims description 7
- 244000046052 Phaseolus vulgaris Species 0.000 claims description 7
- 230000001580 bacterial effect Effects 0.000 claims description 7
- 235000010627 Phaseolus vulgaris Nutrition 0.000 claims description 6
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims description 6
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 claims description 6
- 235000005822 corn Nutrition 0.000 claims description 6
- 241001233957 eudicotyledons Species 0.000 claims description 6
- 235000013312 flour Nutrition 0.000 claims description 6
- 241000894007 species Species 0.000 claims description 6
- 230000001131 transforming effect Effects 0.000 claims description 6
- 235000015872 dietary supplement Nutrition 0.000 claims description 5
- 230000008929 regeneration Effects 0.000 claims description 5
- 238000011069 regeneration method Methods 0.000 claims description 5
- 235000013322 soy milk Nutrition 0.000 claims description 5
- 244000294411 Mirabilis expansa Species 0.000 claims description 4
- 235000015429 Mirabilis expansa Nutrition 0.000 claims description 4
- 206010028980 Neoplasm Diseases 0.000 claims description 4
- 235000019764 Soybean Meal Nutrition 0.000 claims description 4
- 235000013527 bean curd Nutrition 0.000 claims description 4
- 201000011510 cancer Diseases 0.000 claims description 4
- 235000013536 miso Nutrition 0.000 claims description 4
- 235000013557 nattō Nutrition 0.000 claims description 4
- 239000004455 soybean meal Substances 0.000 claims description 4
- 235000013548 tempeh Nutrition 0.000 claims description 4
- 241000700605 Viruses Species 0.000 claims description 3
- 235000012000 cholesterol Nutrition 0.000 claims description 3
- 150000001875 compounds Chemical class 0.000 claims description 3
- 230000003247 decreasing effect Effects 0.000 claims description 3
- 210000005253 yeast cell Anatomy 0.000 claims description 3
- 241001133760 Acoelorraphe Species 0.000 claims description 2
- 241000219194 Arabidopsis Species 0.000 claims description 2
- 235000017060 Arachis glabrata Nutrition 0.000 claims description 2
- 244000105624 Arachis hypogaea Species 0.000 claims description 2
- 235000010777 Arachis hypogaea Nutrition 0.000 claims description 2
- 235000018262 Arachis monticola Nutrition 0.000 claims description 2
- 235000011331 Brassica Nutrition 0.000 claims description 2
- 241000219198 Brassica Species 0.000 claims description 2
- 244000020518 Carthamus tinctorius Species 0.000 claims description 2
- 235000003255 Carthamus tinctorius Nutrition 0.000 claims description 2
- 206010009944 Colon cancer Diseases 0.000 claims description 2
- 229920000742 Cotton Polymers 0.000 claims description 2
- 241000219146 Gossypium Species 0.000 claims description 2
- 244000020551 Helianthus annuus Species 0.000 claims description 2
- 235000003222 Helianthus annuus Nutrition 0.000 claims description 2
- 240000005979 Hordeum vulgare Species 0.000 claims description 2
- 235000007340 Hordeum vulgare Nutrition 0.000 claims description 2
- 235000007688 Lycopersicon esculentum Nutrition 0.000 claims description 2
- 244000061176 Nicotiana tabacum Species 0.000 claims description 2
- 235000002637 Nicotiana tabacum Nutrition 0.000 claims description 2
- 240000007594 Oryza sativa Species 0.000 claims description 2
- 235000007164 Oryza sativa Nutrition 0.000 claims description 2
- 240000003768 Solanum lycopersicum Species 0.000 claims description 2
- 244000061456 Solanum tuberosum Species 0.000 claims description 2
- 235000002595 Solanum tuberosum Nutrition 0.000 claims description 2
- 244000299461 Theobroma cacao Species 0.000 claims description 2
- 235000009470 Theobroma cacao Nutrition 0.000 claims description 2
- 208000029742 colonic neoplasm Diseases 0.000 claims description 2
- 238000005336 cracking Methods 0.000 claims description 2
- 230000037361 pathway Effects 0.000 claims description 2
- 235000020232 peanut Nutrition 0.000 claims description 2
- 235000009566 rice Nutrition 0.000 claims description 2
- 230000000975 bioactive effect Effects 0.000 claims 2
- 230000000415 inactivating effect Effects 0.000 claims 2
- 101710162629 Trypsin inhibitor Proteins 0.000 claims 1
- 229940122618 Trypsin inhibitor Drugs 0.000 claims 1
- 235000004458 antinutrient Nutrition 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 239000002904 solvent Substances 0.000 claims 1
- 239000002753 trypsin inhibitor Substances 0.000 claims 1
- 230000000692 anti-sense effect Effects 0.000 abstract description 6
- 238000010276 construction Methods 0.000 abstract 1
- 239000002299 complementary DNA Substances 0.000 description 62
- 102000004169 proteins and genes Human genes 0.000 description 34
- 235000018102 proteins Nutrition 0.000 description 32
- 239000012634 fragment Substances 0.000 description 31
- 239000013612 plasmid Substances 0.000 description 24
- 210000001519 tissue Anatomy 0.000 description 22
- 235000001014 amino acid Nutrition 0.000 description 20
- 229940024606 amino acid Drugs 0.000 description 20
- 108091026890 Coding region Proteins 0.000 description 18
- 238000003752 polymerase chain reaction Methods 0.000 description 17
- 239000002609 medium Substances 0.000 description 16
- 238000013519 translation Methods 0.000 description 16
- 230000014616 translation Effects 0.000 description 16
- 239000013598 vector Substances 0.000 description 16
- 108020004999 messenger RNA Proteins 0.000 description 15
- 239000002245 particle Substances 0.000 description 15
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 14
- 230000003321 amplification Effects 0.000 description 14
- 238000013507 mapping Methods 0.000 description 14
- 238000003199 nucleic acid amplification method Methods 0.000 description 14
- 230000009466 transformation Effects 0.000 description 14
- 210000002257 embryonic structure Anatomy 0.000 description 13
- LWTDZKXXJRRKDG-KXBFYZLASA-N (-)-phaseollin Chemical compound C1OC2=CC(O)=CC=C2[C@H]2[C@@H]1C1=CC=C3OC(C)(C)C=CC3=C1O2 LWTDZKXXJRRKDG-KXBFYZLASA-N 0.000 description 10
- 240000004371 Panax ginseng Species 0.000 description 10
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 10
- 238000006243 chemical reaction Methods 0.000 description 10
- 230000000694 effects Effects 0.000 description 10
- 235000008434 ginseng Nutrition 0.000 description 10
- 230000002068 genetic effect Effects 0.000 description 9
- 230000004048 modification Effects 0.000 description 9
- 238000012986 modification Methods 0.000 description 9
- 238000003786 synthesis reaction Methods 0.000 description 9
- 108020004635 Complementary DNA Proteins 0.000 description 8
- 230000015572 biosynthetic process Effects 0.000 description 8
- 239000000523 sample Substances 0.000 description 8
- 238000013518 transcription Methods 0.000 description 8
- 230000035897 transcription Effects 0.000 description 8
- 108020004705 Codon Proteins 0.000 description 7
- 108010076161 Cycloartenol synthase Proteins 0.000 description 7
- 230000000408 embryogenic effect Effects 0.000 description 7
- 239000013604 expression vector Substances 0.000 description 7
- 239000007788 liquid Substances 0.000 description 7
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 description 6
- 108020005544 Antisense RNA Proteins 0.000 description 6
- 206010020649 Hyperkeratosis Diseases 0.000 description 6
- 235000002789 Panax ginseng Nutrition 0.000 description 6
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 6
- 108010055615 Zein Proteins 0.000 description 6
- 239000003184 complementary RNA Substances 0.000 description 6
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N dodecahydrosqualene Natural products CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 6
- 239000000796 flavoring agent Substances 0.000 description 6
- 235000019634 flavors Nutrition 0.000 description 6
- 230000035772 mutation Effects 0.000 description 6
- 239000013600 plasmid vector Substances 0.000 description 6
- 108091008146 restriction endonucleases Proteins 0.000 description 6
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 6
- 229940031439 squalene Drugs 0.000 description 6
- 150000003432 sterols Chemical class 0.000 description 6
- 239000000725 suspension Substances 0.000 description 6
- QYIMSPSDBYKPPY-RSKUXYSASA-N (S)-2,3-epoxysqualene Chemical compound CC(C)=CCC\C(C)=C\CC\C(C)=C\CC\C=C(/C)CC\C=C(/C)CC[C@@H]1OC1(C)C QYIMSPSDBYKPPY-RSKUXYSASA-N 0.000 description 5
- 108700010070 Codon Usage Proteins 0.000 description 5
- QYIMSPSDBYKPPY-UHFFFAOYSA-N OS Natural products CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC1OC1(C)C QYIMSPSDBYKPPY-UHFFFAOYSA-N 0.000 description 5
- 101710163504 Phaseolin Proteins 0.000 description 5
- 229930182558 Sterol Natural products 0.000 description 5
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 description 5
- 238000004422 calculation algorithm Methods 0.000 description 5
- 238000010367 cloning Methods 0.000 description 5
- 238000005516 engineering process Methods 0.000 description 5
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 5
- 229910052737 gold Inorganic materials 0.000 description 5
- 239000010931 gold Substances 0.000 description 5
- 235000009973 maize Nutrition 0.000 description 5
- 239000012528 membrane Substances 0.000 description 5
- LWTDZKXXJRRKDG-UHFFFAOYSA-N phaseollin Natural products C1OC2=CC(O)=CC=C2C2C1C1=CC=C3OC(C)(C)C=CC3=C1O2 LWTDZKXXJRRKDG-UHFFFAOYSA-N 0.000 description 5
- 239000002243 precursor Substances 0.000 description 5
- 230000000392 somatic effect Effects 0.000 description 5
- 235000003702 sterols Nutrition 0.000 description 5
- 238000011144 upstream manufacturing Methods 0.000 description 5
- 108091060211 Expressed sequence tag Proteins 0.000 description 4
- 108091092195 Intron Proteins 0.000 description 4
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 4
- 235000003140 Panax quinquefolius Nutrition 0.000 description 4
- 108700001094 Plant Genes Proteins 0.000 description 4
- 229920002494 Zein Polymers 0.000 description 4
- 239000002585 base Substances 0.000 description 4
- ONQRKEUAIJMULO-YBXTVTTCSA-N cycloartenol Chemical compound CC(C)([C@@H](O)CC1)[C@H]2[C@@]31C[C@@]13CC[C@]3(C)[C@@H]([C@@H](CCC=C(C)C)C)CC[C@@]3(C)[C@@H]1CC2 ONQRKEUAIJMULO-YBXTVTTCSA-N 0.000 description 4
- 230000001419 dependent effect Effects 0.000 description 4
- 238000009396 hybridization Methods 0.000 description 4
- 238000003780 insertion Methods 0.000 description 4
- 230000037431 insertion Effects 0.000 description 4
- 238000002955 isolation Methods 0.000 description 4
- 239000003550 marker Substances 0.000 description 4
- 230000004060 metabolic process Effects 0.000 description 4
- 230000000813 microbial effect Effects 0.000 description 4
- 235000016709 nutrition Nutrition 0.000 description 4
- 230000008488 polyadenylation Effects 0.000 description 4
- 238000007363 ring formation reaction Methods 0.000 description 4
- 238000002864 sequence alignment Methods 0.000 description 4
- 239000006228 supernatant Substances 0.000 description 4
- 238000004114 suspension culture Methods 0.000 description 4
- 230000008685 targeting Effects 0.000 description 4
- 150000003505 terpenes Chemical class 0.000 description 4
- 239000005019 zein Substances 0.000 description 4
- 229940093612 zein Drugs 0.000 description 4
- XBZYWSMVVKYHQN-MYPRUECHSA-N (4as,6as,6br,8ar,9r,10s,12ar,12br,14bs)-10-hydroxy-2,2,6a,6b,9,12a-hexamethyl-9-[(sulfooxy)methyl]-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-icosahydropicene-4a-carboxylic acid Chemical compound C1C[C@H](O)[C@@](C)(COS(O)(=O)=O)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C XBZYWSMVVKYHQN-MYPRUECHSA-N 0.000 description 3
- XZEUYTKSAYNYPK-UHFFFAOYSA-N 3beta-29-Norcycloart-24-en-3-ol Natural products C1CC2(C)C(C(CCC=C(C)C)C)CCC2(C)C2CCC3C(C)C(O)CCC33C21C3 XZEUYTKSAYNYPK-UHFFFAOYSA-N 0.000 description 3
- 108030005295 Beta-amyrin synthases Proteins 0.000 description 3
- RRTBTJPVUGMUNR-UHFFFAOYSA-N Cycloartanol Natural products C12CCC(C(C(O)CC3)(C)C)C3C2(CC)CCC2(C)C1(C)CCC2C(C)CCCC(C)C RRTBTJPVUGMUNR-UHFFFAOYSA-N 0.000 description 3
- 108010082495 Dietary Plant Proteins Proteins 0.000 description 3
- 241000588724 Escherichia coli Species 0.000 description 3
- HVXLSFNCWWWDPA-UHFFFAOYSA-N Isocycloartenol Natural products C1CC(O)C(C)(C)C2C31CC13CCC3(C)C(C(CCCC(C)=C)C)CCC3(C)C1CC2 HVXLSFNCWWWDPA-UHFFFAOYSA-N 0.000 description 3
- 108091034117 Oligonucleotide Proteins 0.000 description 3
- HXQRIQXPGMPSRW-UHZRDUGNSA-N Pollinastanol Natural products O[C@@H]1C[C@H]2[C@@]3([C@]4([C@H]([C@@]5(C)[C@@](C)([C@H]([C@H](CCCC(C)C)C)CC5)CC4)CC2)C3)CC1 HXQRIQXPGMPSRW-UHZRDUGNSA-N 0.000 description 3
- 108010076504 Protein Sorting Signals Proteins 0.000 description 3
- 238000002105 Southern blotting Methods 0.000 description 3
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 3
- 239000011543 agarose gel Substances 0.000 description 3
- 230000004075 alteration Effects 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 238000004364 calculation method Methods 0.000 description 3
- 238000005119 centrifugation Methods 0.000 description 3
- YNBJLDSWFGUFRT-UHFFFAOYSA-N cycloartenol Natural products CC(CCC=C(C)C)C1CCC2(C)C1(C)CCC34CC35CCC(O)C(C)(C)C5CCC24C YNBJLDSWFGUFRT-UHFFFAOYSA-N 0.000 description 3
- FODTZLFLDFKIQH-UHFFFAOYSA-N cycloartenol trans-ferulate Natural products C1=C(O)C(OC)=CC(C=CC(=O)OC2C(C3CCC4C5(C)CCC(C5(C)CCC54CC53CC2)C(C)CCC=C(C)C)(C)C)=C1 FODTZLFLDFKIQH-UHFFFAOYSA-N 0.000 description 3
- 238000013461 design Methods 0.000 description 3
- 229910052734 helium Inorganic materials 0.000 description 3
- 239000001307 helium Substances 0.000 description 3
- SWQJXJOGLNCZEY-UHFFFAOYSA-N helium atom Chemical compound [He] SWQJXJOGLNCZEY-UHFFFAOYSA-N 0.000 description 3
- 238000000338 in vitro Methods 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 108010082527 phosphinothricin N-acetyltransferase Proteins 0.000 description 3
- 238000012216 screening Methods 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 238000012546 transfer Methods 0.000 description 3
- 230000014621 translational initiation Effects 0.000 description 3
- INLFWQCRAJUDCR-IQVMEADQSA-N (1R,2S,4S,5'S,6R,7S,8R,9S,12S,13S)-5',7,9,13-tetramethylspiro[5-oxapentacyclo[10.8.0.02,9.04,8.013,18]icosane-6,2'-oxane] Chemical class O([C@@H]1[C@@H]([C@]2(CC[C@@H]3[C@@]4(C)CCCCC4CC[C@H]3[C@@H]2C1)C)[C@@H]1C)[C@]11CC[C@H](C)CO1 INLFWQCRAJUDCR-IQVMEADQSA-N 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 2
- 229920000936 Agarose Polymers 0.000 description 2
- 241000589155 Agrobacterium tumefaciens Species 0.000 description 2
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 2
- 241000701489 Cauliflower mosaic virus Species 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 102000012410 DNA Ligases Human genes 0.000 description 2
- 108010061982 DNA Ligases Proteins 0.000 description 2
- 102000004594 DNA Polymerase I Human genes 0.000 description 2
- 108010017826 DNA Polymerase I Proteins 0.000 description 2
- 239000003298 DNA probe Substances 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 108010077850 Nuclear Localization Signals Proteins 0.000 description 2
- 108020004711 Nucleic Acid Probes Proteins 0.000 description 2
- 238000012408 PCR amplification Methods 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- IAJOBQBIJHVGMQ-UHFFFAOYSA-N Phosphinothricin Natural products CP(O)(=O)CCC(N)C(O)=O IAJOBQBIJHVGMQ-UHFFFAOYSA-N 0.000 description 2
- 108010064851 Plant Proteins Proteins 0.000 description 2
- 108091034057 RNA (poly(A)) Proteins 0.000 description 2
- 101000702488 Rattus norvegicus High affinity cationic amino acid transporter 1 Proteins 0.000 description 2
- 108091081024 Start codon Proteins 0.000 description 2
- 238000005273 aeration Methods 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 2
- 229960000723 ampicillin Drugs 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 238000002869 basic local alignment search tool Methods 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 2
- 235000013361 beverage Nutrition 0.000 description 2
- 239000001110 calcium chloride Substances 0.000 description 2
- 229910001628 calcium chloride Inorganic materials 0.000 description 2
- 210000003763 chloroplast Anatomy 0.000 description 2
- 108010031100 chloroplast transit peptides Proteins 0.000 description 2
- 230000001276 controlling effect Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 210000002472 endoplasmic reticulum Anatomy 0.000 description 2
- 239000003623 enhancer Substances 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 235000013350 formula milk Nutrition 0.000 description 2
- 239000012737 fresh medium Substances 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 230000002363 herbicidal effect Effects 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 125000001165 hydrophobic group Chemical group 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 238000007901 in situ hybridization Methods 0.000 description 2
- 238000002372 labelling Methods 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- MYWUZJCMWCOHBA-VIFPVBQESA-N methamphetamine Chemical compound CN[C@@H](C)CC1=CC=CC=C1 MYWUZJCMWCOHBA-VIFPVBQESA-N 0.000 description 2
- 238000010369 molecular cloning Methods 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 108010058731 nopaline synthase Proteins 0.000 description 2
- 239000002853 nucleic acid probe Substances 0.000 description 2
- 230000002018 overexpression Effects 0.000 description 2
- 235000019629 palatability Nutrition 0.000 description 2
- 101150113864 pat gene Proteins 0.000 description 2
- YBYRMVIVWMBXKQ-UHFFFAOYSA-N phenylmethanesulfonyl fluoride Chemical compound FS(=O)(=O)CC1=CC=CC=C1 YBYRMVIVWMBXKQ-UHFFFAOYSA-N 0.000 description 2
- 230000000243 photosynthetic effect Effects 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 230000022532 regulation of transcription, DNA-dependent Effects 0.000 description 2
- 230000010076 replication Effects 0.000 description 2
- 238000007894 restriction fragment length polymorphism technique Methods 0.000 description 2
- 230000000717 retained effect Effects 0.000 description 2
- 239000006152 selective media Substances 0.000 description 2
- 238000012163 sequencing technique Methods 0.000 description 2
- 230000035939 shock Effects 0.000 description 2
- 235000013555 soy sauce Nutrition 0.000 description 2
- ATHGHQPFGPMSJY-UHFFFAOYSA-N spermidine Chemical compound NCCCCNCCCN ATHGHQPFGPMSJY-UHFFFAOYSA-N 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- -1 sterols and saponins Chemical class 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 230000001629 suppression Effects 0.000 description 2
- 230000005030 transcription termination Effects 0.000 description 2
- KZJWDPNRJALLNS-VPUBHVLGSA-N (-)-beta-Sitosterol Natural products O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@@](C)([C@H]([C@H](CC[C@@H](C(C)C)CC)C)CC4)CC3)CC=2)CC1 KZJWDPNRJALLNS-VPUBHVLGSA-N 0.000 description 1
- CSVWWLUMXNHWSU-UHFFFAOYSA-N (22E)-(24xi)-24-ethyl-5alpha-cholest-22-en-3beta-ol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(CC)C(C)C)C1(C)CC2 CSVWWLUMXNHWSU-UHFFFAOYSA-N 0.000 description 1
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 1
- QYIMSPSDBYKPPY-BANQPHDMSA-N 2,3-epoxysqualene Chemical compound CC(C)=CCC\C(C)=C\CC\C(C)=C\CC\C=C(/C)CC\C=C(/C)CCC1OC1(C)C QYIMSPSDBYKPPY-BANQPHDMSA-N 0.000 description 1
- 239000005631 2,4-Dichlorophenoxyacetic acid Substances 0.000 description 1
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- VWFJDQUYCIWHTN-YFVJMOTDSA-N 2-trans,6-trans-farnesyl diphosphate Chemical compound CC(C)=CCC\C(C)=C\CC\C(C)=C\CO[P@](O)(=O)OP(O)(O)=O VWFJDQUYCIWHTN-YFVJMOTDSA-N 0.000 description 1
- KLEXDBGYSOIREE-UHFFFAOYSA-N 24xi-n-propylcholesterol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CCC)C(C)C)C1(C)CC2 KLEXDBGYSOIREE-UHFFFAOYSA-N 0.000 description 1
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 1
- 229930024421 Adenine Natural products 0.000 description 1
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 1
- 241000589158 Agrobacterium Species 0.000 description 1
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 1
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 1
- 108700028369 Alleles Proteins 0.000 description 1
- 241001439211 Almeida Species 0.000 description 1
- 244000105975 Antidesma platyphyllum Species 0.000 description 1
- 241000219195 Arabidopsis thaliana Species 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 206010065687 Bone loss Diseases 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- LPZCCMIISIBREI-MTFRKTCUSA-N Citrostadienol Natural products CC=C(CC[C@@H](C)[C@H]1CC[C@H]2C3=CC[C@H]4[C@H](C)[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)C LPZCCMIISIBREI-MTFRKTCUSA-N 0.000 description 1
- 102000053602 DNA Human genes 0.000 description 1
- 238000001712 DNA sequencing Methods 0.000 description 1
- ARVGMISWLZPBCH-UHFFFAOYSA-N Dehydro-beta-sitosterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)CCC(CC)C(C)C)CCC33)C)C3=CC=C21 ARVGMISWLZPBCH-UHFFFAOYSA-N 0.000 description 1
- 108091006149 Electron carriers Proteins 0.000 description 1
- YQYJSBFKSSDGFO-UHFFFAOYSA-N Epihygromycin Natural products OC1C(O)C(C(=O)C)OC1OC(C(=C1)O)=CC=C1C=C(C)C(=O)NC1C(O)C(O)C2OCOC2C1O YQYJSBFKSSDGFO-UHFFFAOYSA-N 0.000 description 1
- 241001198387 Escherichia coli BL21(DE3) Species 0.000 description 1
- 101000686777 Escherichia phage T7 T7 RNA polymerase Proteins 0.000 description 1
- 108091092566 Extrachromosomal DNA Proteins 0.000 description 1
- VWFJDQUYCIWHTN-UHFFFAOYSA-N Farnesyl pyrophosphate Natural products CC(C)=CCCC(C)=CCCC(C)=CCOP(O)(=O)OP(O)(O)=O VWFJDQUYCIWHTN-UHFFFAOYSA-N 0.000 description 1
- 230000010558 Gene Alterations Effects 0.000 description 1
- 241000482313 Globodera ellingtonae Species 0.000 description 1
- 239000005561 Glufosinate Substances 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 208000033830 Hot Flashes Diseases 0.000 description 1
- 206010060800 Hot flush Diseases 0.000 description 1
- 102000004286 Hydroxymethylglutaryl CoA Reductases Human genes 0.000 description 1
- 108090000895 Hydroxymethylglutaryl CoA Reductases Proteins 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- 239000006137 Luria-Bertani broth Substances 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 108091027974 Mature messenger RNA Proteins 0.000 description 1
- 208000009869 Neu-Laxova syndrome Diseases 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 229930186185 Polyprenol Natural products 0.000 description 1
- 229920001731 Polyprenol Polymers 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- 108010029485 Protein Isoforms Proteins 0.000 description 1
- 102000001708 Protein Isoforms Human genes 0.000 description 1
- 108020004518 RNA Probes Proteins 0.000 description 1
- 239000003391 RNA probe Substances 0.000 description 1
- 108020004511 Recombinant DNA Proteins 0.000 description 1
- 241000235070 Saccharomyces Species 0.000 description 1
- 108010016634 Seed Storage Proteins Proteins 0.000 description 1
- 238000012300 Sequence Analysis Methods 0.000 description 1
- 102000005782 Squalene Monooxygenase Human genes 0.000 description 1
- 108020003891 Squalene monooxygenase Proteins 0.000 description 1
- 108700019146 Transgenes Proteins 0.000 description 1
- HZYXFRGVBOPPNZ-UHFFFAOYSA-N UNPD88870 Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)=CCC(CC)C(C)C)C1(C)CC2 HZYXFRGVBOPPNZ-UHFFFAOYSA-N 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 229960000643 adenine Drugs 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- MJVXAPPOFPTTCA-UHFFFAOYSA-N beta-Sistosterol Natural products CCC(CCC(C)C1CCC2C3CC=C4C(C)C(O)CCC4(C)C3CCC12C)C(C)C MJVXAPPOFPTTCA-UHFFFAOYSA-N 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Natural products CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 description 1
- 230000002457 bidirectional effect Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 210000004899 c-terminal region Anatomy 0.000 description 1
- 150000001720 carbohydrates Chemical group 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 230000030570 cellular localization Effects 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 230000002759 chromosomal effect Effects 0.000 description 1
- 239000013599 cloning vector Substances 0.000 description 1
- 238000004590 computer program Methods 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 238000012217 deletion Methods 0.000 description 1
- 230000037430 deletion Effects 0.000 description 1
- 230000017858 demethylation Effects 0.000 description 1
- 238000010520 demethylation reaction Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- WQLVFSAGQJTQCK-UHFFFAOYSA-N diosgenin Natural products CC1C(C2(CCC3C4(C)CCC(O)CC4=CCC3C2C2)C)C2OC11CCC(C)CO1 WQLVFSAGQJTQCK-UHFFFAOYSA-N 0.000 description 1
- 229930004069 diterpene Natural products 0.000 description 1
- 125000000567 diterpene group Chemical group 0.000 description 1
- 230000001214 effect on cellular process Effects 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 230000030583 endoplasmic reticulum localization Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000009585 enzyme analysis Methods 0.000 description 1
- 238000001976 enzyme digestion Methods 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 1
- 229960005542 ethidium bromide Drugs 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000005187 foaming Methods 0.000 description 1
- 239000012458 free base Substances 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 230000030279 gene silencing Effects 0.000 description 1
- 238000012226 gene silencing method Methods 0.000 description 1
- 238000012252 genetic analysis Methods 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 238000011331 genomic analysis Methods 0.000 description 1
- 230000035784 germination Effects 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- IAJOBQBIJHVGMQ-BYPYZUCNSA-N glufosinate-P Chemical compound CP(O)(=O)CC[C@H](N)C(O)=O IAJOBQBIJHVGMQ-BYPYZUCNSA-N 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 102000005396 glutamine synthetase Human genes 0.000 description 1
- 108020002326 glutamine synthetase Proteins 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 235000009424 haa Nutrition 0.000 description 1
- 230000002949 hemolytic effect Effects 0.000 description 1
- 239000004009 herbicide Substances 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 230000033444 hydroxylation Effects 0.000 description 1
- 238000005805 hydroxylation reaction Methods 0.000 description 1
- 108010002685 hygromycin-B kinase Proteins 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 239000000411 inducer Substances 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 1
- 239000004816 latex Substances 0.000 description 1
- 229920000126 latex Polymers 0.000 description 1
- 238000007834 ligase chain reaction Methods 0.000 description 1
- 210000001161 mammalian embryo Anatomy 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 230000035800 maturation Effects 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 229930003658 monoterpene Natural products 0.000 description 1
- 150000002773 monoterpene derivatives Chemical class 0.000 description 1
- 235000002577 monoterpenes Nutrition 0.000 description 1
- 239000003471 mutagenic agent Substances 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 230000001338 necrotic effect Effects 0.000 description 1
- 238000007899 nucleic acid hybridization Methods 0.000 description 1
- 238000001216 nucleic acid method Methods 0.000 description 1
- 238000001821 nucleic acid purification Methods 0.000 description 1
- 235000008935 nutritious Nutrition 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 238000003976 plant breeding Methods 0.000 description 1
- 230000008121 plant development Effects 0.000 description 1
- 235000021118 plant-derived protein Nutrition 0.000 description 1
- 210000002706 plastid Anatomy 0.000 description 1
- 230000010152 pollination Effects 0.000 description 1
- 102000054765 polymorphisms of proteins Human genes 0.000 description 1
- 150000003096 polyprenols Chemical class 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 230000001124 posttranscriptional effect Effects 0.000 description 1
- 239000008057 potassium phosphate buffer Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000000644 propagated effect Effects 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 230000003252 repetitive effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 108091092562 ribozyme Proteins 0.000 description 1
- NWMIYTWHUDFRPL-UHFFFAOYSA-N sapogenin Natural products COC(=O)C1(CO)C(O)CCC2(C)C1CCC3(C)C2CC=C4C5C(C)(O)C(C)CCC5(CCC34C)C(=O)O NWMIYTWHUDFRPL-UHFFFAOYSA-N 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 238000005204 segregation Methods 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 229930004725 sesquiterpene Natural products 0.000 description 1
- 150000004354 sesquiterpene derivatives Chemical class 0.000 description 1
- 238000002741 site-directed mutagenesis Methods 0.000 description 1
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 1
- 229950005143 sitosterol Drugs 0.000 description 1
- 235000015500 sitosterol Nutrition 0.000 description 1
- NLQLSVXGSXCXFE-UHFFFAOYSA-N sitosterol Natural products CC=C(/CCC(C)C1CC2C3=CCC4C(C)C(O)CCC4(C)C3CCC2(C)C1)C(C)C NLQLSVXGSXCXFE-UHFFFAOYSA-N 0.000 description 1
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 1
- 229940071440 soy protein isolate Drugs 0.000 description 1
- 229940063673 spermidine Drugs 0.000 description 1
- 238000003153 stable transfection Methods 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- HCXVJBMSMIARIN-PHZDYDNGSA-N stigmasterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)/C=C/[C@@H](CC)C(C)C)[C@@]1(C)CC2 HCXVJBMSMIARIN-PHZDYDNGSA-N 0.000 description 1
- 229940032091 stigmasterol Drugs 0.000 description 1
- 235000016831 stigmasterol Nutrition 0.000 description 1
- BFDNMXAIBMJLBB-UHFFFAOYSA-N stigmasterol Natural products CCC(C=CC(C)C1CCCC2C3CC=C4CC(O)CCC4(C)C3CCC12C)C(C)C BFDNMXAIBMJLBB-UHFFFAOYSA-N 0.000 description 1
- 230000009469 supplementation Effects 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 150000003535 tetraterpenes Chemical class 0.000 description 1
- 235000009657 tetraterpenes Nutrition 0.000 description 1
- 230000005026 transcription initiation Effects 0.000 description 1
- 238000001890 transfection Methods 0.000 description 1
- 238000000844 transformation Methods 0.000 description 1
- 125000003523 triterpene group Chemical group 0.000 description 1
- 241001515965 unidentified phage Species 0.000 description 1
- 210000003934 vacuole Anatomy 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 230000006438 vascular health Effects 0.000 description 1
- 238000012800 visualization Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
- 238000001262 western blot Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
- A23J3/00—Working-up of proteins for foodstuffs
- A23J3/14—Vegetable proteins
- A23J3/16—Vegetable proteins from soybean
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
- C12N15/8243—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/90—Isomerases (5.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P33/00—Preparation of steroids
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2799/00—Uses of viruses
- C12N2799/02—Uses of viruses as vector
- C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
Definitions
- This invention is in the field of plant molecular biology. More specifically, this invention pertains to nucleic acid sequences encoding enzymes involved in the cyclization of squalene epoxide to form the ring structure precursor to triterpenes, including sterols and saponins, in plants and seeds. This invention also includes transgenic plants where the expression of the nucleic acids of the present invention results in altered levels of triterpenes, including sterols and saponins. Also included in the invention are protein products and food and dietary supplement applications.
- the terpenoids also called isoprenoids, constitute the largest family of natural products with over 22,000 individual compounds of this class having been described.
- the triterpenes or terpenoids (hemiterpenes, monoterpenes, sesquiterpenes, diterpenes, triterpenes, tetraterpenes, polyprenols, and the like) play diverse functional roles in plants as hormones, photosynthetic pigments, electron carriers, mediators of polysaccharide assembly, and structural components of membranes.
- the majority of plant terpenoids are found in resins, latex, waxes, and oils.
- squalene Two molecules of farnesyl pyrophosphate are joined head-to-head to form squalene, a triterpene, in the first dedicated step towards sterol biosynthesis. Squalene is then converted to 2,3-oxidosqualene which, in photosynthetic organisms, maybe converted to the 30 carbon, 4 ring structure, cycloartol or to the 5 ring homolog, ⁇ -amyrin, a sapinogenin precursor. This conversion step is catalyzed by one of at least two oxidosqualene cyclases: cycloartol synthase or ⁇ -amyrin synthase.
- Cycloartenol is formed by the enzyme cycloartol synthase (EC 5.4.99.8), also called 2,3-epoxysqualene-cycloartol cyclase.
- the basic nucleus of cycloartol can be further modified by reactions such as desaturation or demethylation to form the common sterol backbones such as stigmasterol and sitosterol, which can be modified further.
- the ⁇ -amyrin cyclization activity is distinct from cycloartol synthase (Kushiro, T., et al. (1998) Eur. J. Biochem. 256:238-244).
- ⁇ -amyrin synthase catalyzes the cyclization of 2,3-oxidosqualene to ⁇ -amyrin.
- the basic ⁇ -amyrin ring structure may be modified in much the same manner as is the cycloartol structure to give classes of sapogenins. Saponins are glycosylated sapogenins and may play a pathogen defense role in plant tissues.
- Soybean seeds for example, contain several classes of saponins, all of which are formed from one sapogenin ring structure that is modified by hydroxylation and by different carbohydrate moieties.
- Total saponin content varies somewhat by soybean cultivar but is in the range of 0.25% of the seed dry weight (Shiraiwa, M., et al. (1991) Agric. Biol. Chem. 55:323-331).
- saponin was derived from their strong foaming power.
- the physiological function of saponins in soybean seeds is not clear, but they do contribute to the bitter or astringent flavor of soybean seeds (Okubo, K., et al. (1992) Biosci. Biotechnol. Biochem. 56:99-103).
- Saponins are thought to have cholesterol-lowering effects and reduction in colon cancer risk. Besides imparting undesirable flavors to feed and foods, saponins have been shown to have hemolytic action against red blood cells. Soybeans are also involved in the reduction of hot flashes in postmenopausal women, lowering the risk of hormone-related cancer, slowdown of bone loss in osteoporosis and improvement in vascular health. Saponins are believed to be involved in these beneficial soybean effects.
- a variety of processed vegetable protein products are produced from soybean. These range from minimally processed, soy beans and soy nuts such as toasted soy nuts and defatted items such as soybean meal, grits, and flours to more highly processed items such as soy protein concentrates and soy protein isolates. In other soy protein products, such as full- fat soy flour, the oil is not extracted. In addition to these processed products, there are also a number of specialty products based on traditional Oriental processes, which utilize the entire bean as the starting material. Examples include soy milk, soy sauce, tofu, natto, miso, tempeh, and yuba.
- soy protein products in human foods include applying soy protein concentrates and soy protein isolates in nutritional beverage, emulsified meat and whole muscle meat applications; textured soy protein in meat analogues; soy protein isolates in infant formula.
- Facilities and methods to produce protein concentrates and isolates from soybeans are available across the world. To the extent that they are retained in these processed soy fractions and the foods prepared from them, the saponin content of the starting beans influences the flavor of the food.
- the instant invention relates to isolated nucleic acid sequences encoding enzymes involved in triterpene synthesis. Specifically, this invention concerns isolated nucleic acid sequences encoding oxidosqualene cyclase enzymes.
- the present invention relates to an isolated polynucleotide comprising a nucleotide sequence selected from the group consisting of: a first nucleotide sequence encoding a polypeptide of at least 100 amino acids having at least 80% identity based on the Clustal method of alignment when compared to a polypeptide selected from the group consisting of SEQ ID NOs:2, 4, 6, and 8; and a second nucleotide sequence comprising the complement of the first nucleotide sequence.
- the present invention also relates to an isolated polynucleotide comprising a nucleotide sequence having at least 30 contiguous nucleotides derived from a nucleic acid sequence selected from the group consisting of SEQ ID NOs:l, 3, 5, and 7 and the complement of such sequences.
- An isolated polypeptide of at least 100 amino acids that has at least 80% identity based on the Clustal method of alignment when compared to a polypeptide selected from the group consisting of SEQ ID NOs:2, 4, 6, and 8 is also an embodiment of the subject invention.
- the instant invention relates to a chimeric polynucleotide comprising the isolated polynucleotide of the present invention operably linked to suitable a regulatory sequence.
- the instant invention concerns an isolated host cell comprising the chimeric polynucleotide of the present invention.
- the host cell may be selected from the group consisting of a yeast cell, a bacterial cell, and a plant cell.
- the present invention also relates to a virus comprising a chimeric gene encoding the polypeptide of the present invention.
- Compositions, including plants and plant parts, comprising the isolated poypeptide or polynucleotide of the present invention are also embodied by the present invention.
- the invention also includes transformed plants that arise from transformed host cells of higher plants and seeds or grains derived from such transformed plants.
- Such transgenic plant includes those having an altered level of a triterpenoid, such as ⁇ -amyrin.
- the present invention is also directed to an isolated soy protein and a food product.
- the food product may be selected from the group consisting of a soy protein product, soybean meal, soy flour, soy protein concentrate, soy milk, a dietary supplement, nuts, tofu, natto, miso, and tempeh.
- the present invention also relates to a method of altering the level of expression of an oxidosqualene cyclase polypeptide in a plant cell, which comprises: constructing an isolated polynucleotide comprising a nucleotide sequence of at least 30 contiguous nucleotides derived from an isolated polynucleotide of the present invention; introducing the isolated polynucleotide into a plant cell; measuring the level of oxidosqualene cyclase in the plant cell containing the polynucleotide; and comparing the level of oxidosqualene cyclase in the plant cell containing the isolated polynucleotide with the level of oxidosqualene cyclase in a plant cell of the same species as the plant cell of step (b) that does not contain the isolated polynucleotide.
- Another embodiment of the present invention is a method of producing a plant with altered levels of oxidosqualene cyclase comprising: transforming a plant cell with the chimeric polynucleotide of the present invention; growing the transformed plant cell from step (a) under conditions that promote the regeneration of a whole plant from the transformed cell, wherein the plant regenerated from the transformed cell produces an amount of oxidosqualene cyclase that is greater than the amount of the oxidosqualene cyclase that is produced in a plant that is regenerated from a plant cell of the same species as the plant of step (a) that is not transformed with the chimeric polynucleotide; and optionally transforming the plant cell of step (a) with a second chimeric polynucleotide comprising a nucleic acid sequence encoding a polypeptide that regulates expression of at least one enzyme of the triterpenoid pathway; and growing the transformed plant cell from step (c) under conditions that promote the
- the present invention also relates to: (1) a method of making a soy protein product comprising processing the grain of the present invention, said processing including: toasting or cracking said grain to remove the meats from the hulls; and flaking the meats obtained in step (a) to obtain a desired flake thickness, and (2) a method for positive selection of a transformed cell comprising: transforming a host cell with the chimeric gene of the present invention; and growing the transformed host cell under conditions which allow expression of the oxidosqualene cyclase polynucleotide in an amount sufficient to complement a null mutant to provide a positive selection means.
- Figure 1 depicts the amino acid sequence alignment between the oxidosqualene cyclases encoded by soybean clones sdp3c.pk020.ol0 (SEQ ID NO:2), src3c.pk024.ml 1 (SEQ ID NO:4), sahlc.pk002.n23 (SEQ ID NO:6), wheat clone wdklc.pkOlO.olO (SEQ ID NO: 8) and the ⁇ -amyrin synthases from Panax ginseng (NCBI General Identifier
- SEQ ID NO: l is the nucleotide sequence comprising the soybean cDNA insert in clone sdp3c.pk020.ol0 encoding a soybean oxidosqualene cyclase.
- SEQ ID NO:2 is the deduced amino acid sequence of a soybean oxidosqualene cyclase derived from the nucleotide sequence of SEQ ID NO: l.
- SEQ ID NO: 3 is the nucleotide sequence comprising the soybean cDNA insert in clone src3c.pk024.ml 1 encoding a soybean ⁇ -amyrin synthase.
- SEQ ID NO:4 is the deduced amino acid sequence of a soybean ⁇ -amyrin synthase derived from the nucleotide sequence of SEQ ID NO:3.
- SEQ ID NO: 5 is the nucleotide sequence comprising the soybean cDNA insert in clone sahlc.pk002.n23 encoding a soybean oxidosqualene cyclase.
- SEQ ID NO:6 is the deduced amino acid sequence of a soybean oxidosqualene cyclase derived from the nucleotide sequence of SEQ ID NO:5.
- SEQ ID NO:7 is the nucleotide sequence comprising the wheat cDNA insert in clone wdklc.pkOlO.olO encoding a wheat oxidosqualene cyclase.
- SEQ ID NO:8 is the deduced amino acid sequence of a wheat oxidosqualene cyclase derived from the nucleotide sequence of SEQ ID NO:7.
- SEQ ID NO:9 is the nucleotide sequence of an ohgonucleotide primer used to amplify the cDNA insert from clone src3c.pk0024.ml 1.
- SEQ ID NO: 10 is the nucleotide sequence of an ohgonucleotide primer used to amplify the cDNA insert from clone sahlc.pk002.n23.
- SEQ ED NO: 1 1 is the nucleotide sequence of an ohgonucleotide primer used for PCR amplification of oxidosqualene cyclase sequences from clones src3c.pk0024.ml 1 and sahlc.pk002.n23.
- SEQ ID NO:12 is the amino acid sequence of a P ⁇ n ⁇ x ginseng ⁇ -amyrin synthase having NCBI General Identifier No. 3721856.
- SEQ ID NO: 13 is the amino acid sequence of a P ⁇ n ⁇ x ginseng ⁇ -amyrin synthase having NCBI General Identifier No. 3688600.
- the Sequence Listing contains the one letter code for nucleotide sequence characters and the three letter codes for amino acids as defined in conformity with the IUPAC-IUBMB standards described in Nucleic Acids Research 5:3021-3030 (1985) and in the Biochemical Journal 219 (No. 2):345-313 (1984) which are herein mcorporated by reference.
- the symbols and format used for nucleotide and amino acid sequence data comply with the rules set forth in 37 C.F.R. ⁇ 1.822.
- polynucleotide/isolated polynucleotide and “nucleic acid fragment'V'isolated nucleic acid fragment” are used interchangeably herein. These terms encompass nucleotide sequences and the like.
- a polynucleotide may be a polymer of RNA or DNA that is single- or double- stranded, that optionally contains synthetic, non-natural or altered nucleotide bases.
- a polynucleotide in the form of a polymer of DNA may be comprised of one or more segments of cDNA, genomic DNA, synthetic DNA or mixtures thereof.
- An isolated polynucleotide of the present invention may include at least one of 60 contiguous nucleotides, preferably at least one of 40 contiguous nucleotides, most preferably one of at least 30 contiguous nucleotides derived from a nucleotide sequence selected from the group consisting of SEQ ID NOs:l, 3, 5, and 7, or the complement of such sequences.
- isolated polynucleotide is one that has been substantially separated or purified away from other nucleic acid sequences in the cell of the organism in which the nucleic acid naturally occurs, i.e., other chromosomal and extrachromosomal DNA and RNA, by conventional nucleic acid purification methods.
- isolated polynucleotide also embraces recombinant polynucleotides and chemically synthesized polynucleotides.
- the present invention is directed to isolated polynucleotides and chimeric genes encoding oxidosqualene cyclase enzymes. While not intending to be bound by any theory or theories of operation, it is believed that these enzymes are membrane bound.
- Oxidosqualene cyclases include and are not limited to ⁇ -amyrin synthase, squalene monooxygenase, cycloartol synthase and the like.
- Triterpene synthesis is catalyzed by oxidosqualene cyclases.
- Triterpenes, also known as triterpenoids include and are not limited to sapinogenins and sterols. The sapinogenin, ⁇ -amyrin, is produced by the action of ⁇ -amyrin synthase on 2,3-oxidosqualene, for example.
- substantially similar refers to nucleic acid sequences wherein changes in one or more nucleotide bases results in substitution of one or more amino acids, that do not affect the functional properties of the polypeptide encoded by the nucleic acid sequence. “Substantially similar” also refers to polynucleotides wherein changes in one or more nucleotide bases does not affect the ability of the nucleic acid sequence to mediate alteration of gene expression by antisense or co-suppression technology among others.
- Substantially similar also refers to modifications of the nucleic acid fragments of the instant invention such as deletion or insertion of one or more nucleotides that do not substantially affect the functional properties of the resulting transcript vis-a-vis the ability to mediate gene silencing or alteration of the functional properties of the resulting polpeptide. It is therefore understood that the invention encompasses more than the specific exemplary sequences.
- Substantially similar nucleic acid fragments may be selected by screening nucleic acid fragments representing subfragments or modifications of the nucleic acid fragments of the instant invention, wherein one or more nucleotides are substituted, deleted and/or inserted, for their ability to affect the level of the polypeptide encoded by the unmodified nucleic acid fragment in a plant or plant cell.
- a substantially similar nucleic acid fragment representing at least one of 30 contiguous nucleotides derived from the instant nucleic acid fragment can be constructed and introduced into a plant or plant cell.
- the level of the polypeptide encoded by the unmodified nucleic acid fragment present in a plant or plant cell exposed to the substantially similar nucleic fragment can then be compared to the level of the polypeptide in a plant or plant cell that is not exposed to the substantially similar nucleic acid fragment.
- antisense suppression and co-suppression of gene expression may be accomplished using nucleic acid fragments representing less than the entire coding region of a gene, and by nucleic acid fragments that do not share 100% sequence identity with the gene to be suppressed.
- alterations in a nucleic acid sequence which result in the production of a chemically equivalent amino acid at a given site, but do not effect the functional properties of the encoded polypeptide are well known in the art.
- a codon for the amino acid alanine, a hydrophobic amino acid may be substituted by a codon encoding another less hydrophobic residue, such as glycine, or a more hydrophobic residue such as valine, leucine, or isoleucine.
- a codon encoding another less hydrophobic residue such as glycine, or a more hydrophobic residue such as valine, leucine, or isoleucine.
- changes which result in substitution of one negatively charged residue for another such as aspartic acid for glutamic acid, or one positively charged residue for another, such as lysine for arginine, can also be expected to produce a functionally equivalent product.
- Nucleotide changes which result in alteration of the N-terminal and C-terminal portions of the polypeptide molecule would also not be expected to alter the activity of the polypeptide.
- an isolated polynucleotide comprising a nucleotide sequence of at least one of 60 (preferably at least one of 40, most preferably at least one of 30) contiguous nucleotides derived from a nucleotide sequence selected from the group consisting of SEQ ID NOs:l, 3, 5, and 7 and the complement of such nucleotide sequences may be used in methods of selecting an isolated polynucleotide that affects the expression of an oxidosqualene cyclase polypeptide in a host cell.
- a method of selecting an isolated polynucleotide that affects the level of expression of an oxidosqualene cyclase polypeptide in a host cell may comprise the steps of: constructing an isolated polynucleotide of the present invention or an isolated chimeric gene of the present invention; introducing the isolated polynucleotide or the isolated chimeric gene into a host cell; measuring the level a polypeptide in the host cell containing the isolated polynucleotide; and comparing the level of a polypeptide in the host cell containing the isolated polynucleotide with the level of a polypeptide in a host cell that does not contain the isolated polynucleotide.
- substantially similar nucleic acid fragments may also be characterized by their ability to hybridize. Estimates of such homology are provided by either DNA-DNA or DNA-RNA hybridization under conditions of stringency as is well understood by those skilled in the art (Hames and Higgins, Eds. (1985) Nucleic Acid Hybridisation, IRL Press, Oxford, U.K.). Stringency conditions can be adjusted to screen for moderately similar fragments, such as homologous sequences from distantly related organisms, to highly similar fragments, such as genes that duplicate functional enzymes from closely related organisms. Post-hybridization washes determine stringency conditions.
- One set of preferred conditions uses a series of washes starting with 6X SSC, 0.5% SDS at room temperature for 15 min, then repeated with 2X SSC, 0.5% SDS at 45°C for 30 min, and then repeated twice with 0.2X SSC, 0.5%) SDS at 50°C for 30 min.
- a more preferred set of stringent conditions uses higher temperatures in which the washes are identical to those above except for the temperature of the final two 30 min washes in 0.2X SSC, 0.5% SDS was increased to 60°C.
- Another preferred set of highly stringent conditions uses two final washes in 0.1X SSC, 0.1% SDS at 65°C.
- nucleic acid fragments of the instant invention may also be characterized by the percent identity of the amino acid sequences that they encode to the amino acid sequences disclosed herein, as determined by algorithms commonly employed by those skilled in this art.
- Suitable nucleic acid fragments encode polypeptides that are at least about 70% identical, preferably at least about 80% identical to the amino acid sequences reported herein.
- Preferred nucleic acid fragments encode amino acid sequences that are about 85% identical to the amino acid sequences reported herein. More preferred nucleic acid fragments encode amino acid sequences that are at least about 90% identical to the amino acid sequences reported herein.
- nucleic acid fragments that encode amino acid sequences that are at least about 95% identical to the amino acid sequences reported herein. Suitable nucleic acid fragments not only have the above homologies but typically encode a polypeptide having at least 50 amino acids, preferably at least 100 amino acids, more preferably at least 150 amino acids, still more preferably at least 200 amino acids, and most preferably at least 250 amino acids. Sequence alignments and percent identity calculations were performed using the Megalign program of the LASERGENE bioinformatics computing suite (DNASTAR Inc., Madison, WI). Multiple alignment of the sequences was performed using the Clustal method of alignment (Higgins and Sharp (1989) CABIOS.
- a "substantial portion" of an amino acid or nucleotide sequence comprises an amino acid or a nucleotide sequence that is sufficient to afford putative identification of the protein or gene that the amino acid or nucleotide sequence comprises.
- Amino acid and nucleotide sequences can be evaluated either manually by one skilled in the art, or by using computer- based sequence comparison and identification tools that employ algorithms such as BLAST (Basic Local Alignment Search Tool; Altschul et al, (1993) J. Mol. Biol. 275:403-410; see also www.ncbi.nlm.nih.gov/BLAST/).
- a sequence often or more contiguous amino acids or thirty or more contiguous nucleotides is necessary in order to putatively identify a polypeptide or nucleic acid sequence as homologous to a known protein or gene.
- gene specific ohgonucleotide probes comprising 30 or more contiguous nucleotides may be used in sequence-dependent methods of gene identification (e.g., Southern hybridization) and isolation (e.g., in situ hybridization of bacterial colonies or bacteriophage plaques), hi addition, short oligonucleotides of 12 or more nucleotides may be used as amplification primers in PCR in order to obtain a particular nucleic acid fragment comprising the primers.
- a "substantial portion" of a nucleotide sequence comprises a nucleotide sequence that will afford specific identification and/or isolation of a nucleic acid fragment comprising the sequence.
- the instant specification teaches amino acid and nucleotide sequences encoding polypeptides that comprise one or more particular plant proteins. The skilled artisan, having the benefit of the sequences as reported herein, may now use all or a substantial portion of the disclosed sequences for purposes known to those skilled in this art. Accordingly, the instant invention comprises the complete sequences as reported in the accompanying Sequence Listing, as well as substantial portions of those sequences as defined above.
- Codon degeneracy refers to divergence in the genetic code permitting variation of the nucleotide sequence without effecting the amino acid sequence of an encoded polypeptide. Accordingly, the instant invention relates to any nucleic acid fragment comprising a nucleotide sequence that encodes all or a substantial portion of the amino acid sequence encoding the oxidosqualene cyclase proteins as set forth in SEQ ID NOs:2, 4, 6, and 8.
- the skilled artisan is well aware of the "codon-bias" exhibited by a specific host cell in usage of nucleotide codons to specify a given amino acid.
- Synthetic nucleic acid fragments can be assembled from ohgonucleotide building blocks that are chemically synthesized using procedures known to those skilled in the art. These building blocks are ligated and annealed to form larger nucleic acid fragments which may then be enzymatically assembled to construct the entire desired nucleic acid fragment. "Chemically synthesized”, as related to nucleic acid fragment, means that the component nucleotides were assembled in vitro. Manual chemical synthesis of nucleic acid fragments may be accomplished using well established procedures, or automated chemical synthesis can be performed using one of a number of commercially available machines.
- nucleic acid fragments can be tailored for optimal gene expression based on optimization of nucleotide sequence to reflect the codon bias of the host cell.
- the skilled artisan appreciates the likelihood of successful gene expression if codon usage is biased towards those codons favored by the host. Determination of preferred codons can be based on a survey of genes derived from the host cell where sequence information is available.
- Gene refers to a nucleic acid fragment that expresses a specific protein, including regulatory sequences upstream (5' non-coding sequences), within, and downstream (3' non- coding sequences) the coding sequence.
- Native gene refers to a gene as found in nature with its own regulatory sequences.
- Chimeric or heterologous “gene or polynucleotide” refers any gene or polynucleotide that is not native to a plant. A chimeric or heterologous gene comprises regulatory and coding sequences that are not found together in nature.
- a chimeric gene may comprise regulatory sequences and coding sequences that are derived from different sources, or regulatory sequences and coding sequences derived from the same source, but arranged in a manner different than that found in nature.
- Endogenous gene refers to a native gene in its natural location in the genome of an organism.
- a “foreign” gene refers to a gene not normally found in the host organism, but that is introduced into the host organism by gene transfer.
- Foreign genes can comprise native genes inserted into a non-native organism, or chimeric genes.
- a “transgene” is a gene that has been introduced into the genome by a transformation procedure.
- Coding sequence refers to a nucleotide sequence that codes for a specific amino acid sequence.
- Regulatory sequences refer to nucleotide sequences located upstream (5' non-coding sequences), within, or downstream (3' non-coding sequences) of a coding sequence, and which influence the transcription, RNA processing or stability, or translation of the associated coding sequence. Regulatory sequences may include promoters, translation leader sequences, introns, and polyadenylation recognition sequences.
- Promoter refers to a polynucleotide sequence capable of controlling the expression of a coding sequence or functional RNA.
- a coding sequence is located 3' to a promoter sequence.
- the promoter sequence consists of proximal and more distal upstream elements; the latter elements often referred to as enhancers.
- an “enhancer” is a nucleotide sequence, which can stimulate promoter activity, and may be an innate element of the promoter or a heterologous element inserted to enhance the level or tissue-specificity of a promoter. Promoters may be derived in their entirety from a native gene, or be composed of different elements derived from different promoters found in nature, or even comprise synthetic nucleotide segments.
- promoters may direct the expression of a gene in different tissues or cell types, or at different stages of development, or in response to different environmental conditions. Promoters which cause a gene to be expressed in most cell types at most times are commonly referred to as "constitutive promoters". New promoters of various types useful in plant cells are constantly being discovered; numerous examples may be found in the compilation by
- translation leader sequence refers to a polynucleotide sequence located between the promoter sequence of a gene and the coding sequence.
- the translation leader sequence is present in the fully processed mRNA upstream of the translation start sequence.
- the translation leader sequence may affect processing of the primary transcript to mRNA, mRNA stability or translation efficiency. Examples of translation leader sequences have been described (Turner and Foster (1995) Mol. Biotechnol. 3:225-236).
- the "3' non-coding sequences” refer to DNA sequences located downstream of a coding sequence and include polyadenylation recognition sequences and other sequences encoding regulatory signals capable of affecting mRNA processing or gene expression.
- the polyadenylation signal is usually characterized by affecting the addition of polyadenylic acid tracts to the 3' end of the mRNA precursor.
- the use of different 3' non-coding sequences is exemplified by Ingelbrecht et al. (1989) Plant Cell 7:671-680.
- RNA transcript refers to the product resulting from RNA polymerase-catalyzed transcription of a DNA sequence.
- the primary transcript When the RNA transcript is a perfect complementary copy of the DNA sequence, it is referred to as the primary transcript or it may be a RNA sequence derived from posttranscriptional processing of the primary transcript and is referred to as the mature RNA.
- Messenger RNA (mRNA) refers to the RNA that is without introns and that can be translated into protein by the cell.
- cDNA refers to a DNA that is complementary to and derived from an mRNA. The cDNA can be single-stranded or converted into the double stranded form using, for example, the klenow fragment of DNA polymerase I.
- Sense RNA refers to RNA transcript that includes the mRNA and so can be translated into a polypeptide by the cell.
- Antisense RNA refers to an RNA transcript that is complementary to all or part of a target primary transcript or mRNA and that blocks the expression of a target gene (see U.S. Patent No. 5,107,065, incorporated herein by reference). The complementarity of an antisense RNA may be with any part of the specific gene transcript, i.e., at the 5' non-coding sequence, 3' non-coding sequence, introns, or the coding sequence.
- RNA refers to sense RNA, antisense RNA, ribozyme RNA, or other RNA that may not be translated but yet has an effect on cellular processes.
- operably linked refers to the association of nucleic acid sequences on a single polynucleotide so that the function of one is affected by the other.
- a promoter is operably linked with a coding sequence when it is capable of affecting the expression of that coding sequence (i.e., that the coding sequence is under the transcriptional control of the promoter). Coding sequences can be operably linked to regulatory sequences in sense or antisense orientation.
- recombinant means, for example, that a recombinant nucleic acid sequence is made by an artificial combination of two otherwise separated segments of sequence, e.g., by chemical synthesis or by the manipulation of isolated segments of nucleic acids by genetic engineering techniques.
- expression refers to the transcription and stable accumulation of sense (mRNA) or antisense RNA derived from a polynucleotide of the invention. Expression may also refer to translation of mRNA into a polypeptide.
- Antisense inhibition refers to the production of antisense RNA transcripts capable of suppressing the expression of the target protein.
- RNA transcripts capable of suppressing the expression of identical or substantially similar foreign or endogenous genes (U.S. Patent No. 5,231,020, incorporated herein by reference).
- altered levels or “altered expression” refers to the production of gene product(s) in transgenic organisms in amounts or proportions that differ from that of normal or non- transformed organisms.
- “Mature” protein refers to a pos ' t-translationally processed polypeptide; i.e., one from which any pre- or pro-peptides present in the primary translation product have been removed.
- Precursor protein refers to the primary product of translation of mRNA; i.e., with pre- and propeptides still present. Pre- and pro-peptides may be but are not limited to intracellular localization signals.
- a “signal peptide” is an amino acid sequence which is translated in conjunction with a protein and directs the protein to the secretory system (Chrispeels (1991) Ann. Rev. Plant Phys. Plant Mol. Biol. 42:21-53). If the protein is to be directed to a vacuole, a vacuolar targeting signal (supra) can further be added, or if to the endoplasmic reticulum, an endoplasmic reticulum retention signal (supra) may be added. If the protein is to be directed to the nucleus, any signal peptide present should be removed and instead a nuclear localization signal included (Raikhel (1992) Plant Phys.100: 1627- 1632).
- chloroplast transit peptide is an amino acid sequence which is translated in conjunction with a protein and directs the protein to the chloroplast or other plastid types present in the cell in which the protein is made.
- Chloroplast transit sequence refers to a nucleotide sequence that encodes a chloroplast transit peptide.
- Transformation refers to the transfer of a nucleic acid fragment into the genome of a host organism, resulting in genetically stable inheritance. Host organisms containing the transformed nucleic acid fragments are referred to as "transgenic" organisms. Examples of methods of plant transformation include Agrobacterium-mediated transformation (De Blaere et al. (1987) Meth. Enzymol. 143:211) and particle-accelerated or “gene gun” transformation technology (Klein et al. (1987) Nature (London) 327:10-13; U.S. Patent No. 4,945,050, incorporated herein by reference).
- a chimeric oxidosqualene cyclase results in the production of a level of the encoded oxidosqualene cyclase protein in a transformed host cell that is altered as compared to the level produced in an untransformed host cell.
- a transgenic plant, or plant part, comprising a polynucleotide of the present invention, such as for example, SEQ ID NOS:l, 3, 5, and 7, under the control of a heterologous promoter results in plants having altered levels of triterpenes.
- Plants may be selected from the group consisting of monocots and dicots. Monocots include and are not limted to corn, rice, wheat, barley, palm, and the like. Dicots include and are not limited to Arabidopsis, soybean, oilseed Brassica, peanut, sunflower, safflower, cotton, tobacco, tomato, potato, cocoa, and the like.
- Plant parts include and are not limited to seeds and grains, for example.
- isolated polynucleotides of the present invention can be incorporated into recombinant constructs capable of introduction into and replication in a host cell.
- a construct can be a vector that includes a replication system and sequences that are capable of transcription and translation of a polypeptide-encoding sequence in a given host cell.
- vectors suitable for stable transfection of plant cells or for the establishment of transgenic plants have been described in, e.g., Pouwels et al., Cloning Vectors: A Laboratory Manual, 1985, supp. 1987; Weissbach and Weissbach, Methods for Plant Molecular Biology, Academic Press, 1989; and Flevin et al., Plant Molecular Biology Manual, Kluwer Academic Publishers, 1990.
- plant expression vectors include, for example, one or more cloned plant genes under the transcriptional control of 5' and 3' regulatory sequences and a dominant selectable marker.
- plant expression vectors also can contain a promoter regulatory region (e.g., a regulatory region controlling inducible or constitutive, environmentally- or developmentally-regulated, or cell- or tissue-specific expression), a transcription initiation start site, a ribosome binding site, an RNA processing signal, a transcription termination site, and or a polyadenylation signal.
- Standard recombinant DNA and molecular cloning techniques used herein are well known in the art and are described more fully in Sambrook et al. Molecular Cloning: A Laboratory Manual; Cold Spring Harbor Laboratory Press: Cold Spring Harbor, 1989 (hereinafter "Sambrook”).
- PCR or “polymerase chain reaction” is a technique for the synthesis of large quantities of specific DNA segments. It consists of a series of repetitive cycles (Perkin Elmer Cetus fhstruements, Norwark, CT). Typically, the double-stranded DNA is heat denatured, the two primers complementary to the 3' boundaries of the target segments are annealed at low temperature and then extended at an intermediate temperature. One set of these three consecutive steps is referred to as a cycle.
- Nucleic acid fragments encoding oxidosqualene cyclases have been isolated and identified by comparison of random plant cDNA sequences to public databases containing nucleotide and protein sequences using the BLAST algorithms well known to those skilled in the art. Furthermore, their expression has been functionally demonstrated in yeast. Included herein are nucleotide and amino acid sequences with similarities to oxidosqualene cyclase. ⁇ -amyrin synthase converts 2,3-oxidosqualene to ⁇ -amyrin, which is a required step in the synthesis of saponins in soybean seeds. Elimination of saponins may therefore lead to improved flavor.
- the nucleic acid fragments of the instant invention may be used to isolate cDNAs and genes encoding homologous proteins from the same or other plant species. Isolation of homologous genes using sequence-dependent protocols is well known in the art. Examples of sequence-dependent protocols include, but are not limited to, methods of nucleic acid hybridization, and methods of DNA and RNA amplification as exemplified by various uses of nucleic acid amplification technologies (e.g., polymerase chain reaction, ligase chain reaction).
- genes encoding other oxidosqualene cyclases could be isolated directly by using all or a portion of the instant nucleic acid fragments as DNA hybridization probes to screen libraries from any desired plant employing methodology well known to those skilled in the art.
- Specific ohgonucleotide probes based upon the instant nucleic acid sequences can be designed and synthesized by methods known in the art (Sambrook). Moreover, the entire sequences can be used directly to synthesize DNA probes by methods known to the skilled artisan such as random primer DNA labeling, nick translation, or end-labeling techniques, or RNA probes using available in vitro transcription systems.
- primers can be designed and used to amplify a part or all of the instant sequences.
- the resulting amplification products can be labeled directly during amplification reactions or labeled after amplification reactions, and used as probes to isolate full-length cDNA or genomic fragments under conditions of appropriate stringency.
- two short segments of the instant nucleic acid fragments maybe used in polymerase chain reaction protocols to amplify longer nucleic acid fragments encoding homologous genes from DNA or RNA.
- the polymerase chain reaction may also be performed on a library of cloned nucleic acid fragments wherein the sequence of one primer is derived from the instant nucleic acid fragments, and the sequence of the other primer takes advantage of the presence of the polyadenylic acid tracts to the 3' end of the mRNA precursor encoding plant genes.
- the second primer sequence may be based upon sequences derived from the cloning vector. For example, the skilled artisan can follow the RACE protocol (Frohman et al., (1988) Proc. Natl.
- Products generated by the 3' and 5' RACE procedures can be combined to generate full-length cDNAs (Frohman and Martin (1989) Techniques 1:165).
- Availability of the instant nucleotide and deduced amino acid sequences facilitates immunological screening of cDNA expression libraries.
- Synthetic peptides representing portions of the instant amino acid sequences may be synthesized. These peptides can be used to immunize animals to produce polyclonal or monoclonal antibodies with specificity for peptides or proteins comprising the amino acid sequences. These antibodies can be then be used to screen cDNA expression libraries to isolate full-length cDNA clones of interest (Lerner (1984) _4_7v. Immunol. 36:1-34; Sambrook).
- nucleic acid fragments of the instant invention may be used to create transgenic plants in which the disclosed oxidosqualene cyclase is present at higher or lower levels than normal or in cell types or developmental stages in which it is not normally found. This would have the effect of altering the relative sterol composition in those cells. These changes in the plant seed may be useful to improve the seed nutritional value, and in the plant leaf may aid in insect tolerance.
- Overexpression of oxidosqualene cyclase proteins of the instant invention maybe accomplished by first constructing a chimeric gene in which the coding region is operably linked to a promoter capable of directing expression of a gene in the desired tissues at the desired stage of development.
- the chimeric gene may comprise promoter sequences and translation leader sequences derived from the same genes. 3' Non-coding sequences encoding transcription termination signals may also be provided.
- the instant chimeric gene may also comprise one or more introns in order to facilitate gene expression.
- Plasmid vectors comprising the isolated polynucleotide (or chimeric gene) may be constructed.
- the choice of plasmid vector is dependent upon the method that will be used to transform host cells. The skilled artisan is well aware of the genetic elements that must be present on the plasmid vector in order to successfully transform, select and propagate host cells containing the chimeric gene. The skilled artisan will also recognize that different independent transformation events will result in different levels and patterns of expression (Jones et al., (1985) EMBO J. 4:2411-2418; De Almeida et al, (1989) Mol. Gen. Genetics 275:78-86), and thus that multiple events must be screened in order to obtain lines displaying the desired expression level and pattern.
- Such screening may be accomplished by Southern analysis of DNA, Northern analysis of mRNA expression, Western analysis of protein expression, or phenotypic analysis. For some applications it may be useful to direct the instant polypeptide to different cellular compartments, or to facilitate its secretion from the cell. It is thus envisioned that the chimeric gene described above may be further supplemented by altering the coding sequence to encode a triterpenoid with appropriate intracellular targeting sequences such as transit sequences (Keegstra (1989) Cell 56:241-253), signal sequences or sequences encoding endoplasmic reticulum localization (Chrispeels (1991) Ann. Rev. Plant Phys. Plant Mol. Biol.
- a chimeric gene designed for co-suppression of the instant enzymes can be constructed by linking a gene or gene fragment encoding an oxidosqualene cyclase to plant promoter sequences.
- a chimeric gene designed to express antisense RNA for all or part of the instant nucleic acid fragment can be constructed by linking the gene or gene fragment in reverse orientation to plant promoter sequences. Either the co-suppression or antisense chimeric genes could be introduced into plants via transformation wherein expression of the corresponding endogenous genes are reduced or eliminated.
- the instant oxidosqualene cyclase may be produced in heterologous host cells, particularly in the cells of microbial hosts, and can be used to prepare antibodies to these proteins by methods well known to those skilled in the art.
- the antibodies are useful for detecting oxidosqualene cyclase in situ in cells or in vitro in cell extracts.
- Preferred heterologous host cells for production of the instant oxidosqualene cyclase are microbial hosts.
- Microbial expression systems and expression vectors containing regulatory sequences that direct high level expression of foreign proteins are well known to those skilled in the art. Any of these could be used to construct a chimeric gene for production of the instant oxidosqualene cyclase.
- This chimeric gene could then be introduced into appropriate microorganisms via transformation to provide high level expression of the encoded enzymes involved in squalene metabolism.
- An example of a vector for high level expression of the instant oxidosqualene cyclase in a bacterial host is provided (Example 7).
- All or a substantial portion of the nucleic acid fragments of the instant invention may also be used as probes for genetically and physically mapping the genes that they are a part of, and as markers for traits linked to those genes. Such information may be useful in plant breeding in order to develop lines with desired phenotypes.
- the instant nucleic acid fragments may be used as restriction fragment length polymorphism (RFLP) markers.
- RFLP restriction fragment length polymorphism
- Southern blots (Sambrook) of restriction-digested plant genomic DNA may be probed with the nucleic acid fragments of the instant invention.
- the resulting banding patterns may then be subjected to genetic analyses using computer programs such as MapMaker (Lander et al., (1987) Genomics 1:174-181) in order to construct a genetic map.
- the nucleic acid fragments of the instant invention may be used to probe Southern blots containing restriction endonuclease-treated genomic DNAs of a set of individuals representing parent and progeny of a defined genetic cross.
- Nucleic acid probes derived from the instant nucleic acid sequences may also be used for physical mapping (i.e., placement of sequences on physical maps; see Hoheisel et al. In: Nonmammalian Genomic Analysis: A Practical Guide, Academic press 1996, pp. 319-346, and references cited therein).
- nucleic acid probes derived from the instant nucleic acid sequences may be used in direct fluorescence in situ hybridization (FISH) mapping (Trask (1991) Trends Genet. 7:149-154).
- FISH direct fluorescence in situ hybridization
- current methods of FISH mapping favor use of large clones (several to several hundred KB; see Laan et al. (1995) Genome Res. 5:13-20)
- improvements in sensitivity may allow performance of FISH mapping using shorter probes.
- a variety of nucleic acid amplification-based methods of genetic and physical mapping may be carried out using the instant nucleic acid sequences. Examples include allele-specific amplification (Kazazian (1989) J. Lab. Clin. Med.
- Loss of function mutant phenotypes may be identified for the instant cD ⁇ A clones either by targeted gene disruption protocols or by identifying specific mutants for these genes contained in a maize population carrying mutations in all possible genes (Ballinger and Benzer (1989) Proc. Natl. Acad. Sci. USA 86:9402-9406; Koes et al. (1995) Proc. Natl. Acad. Sci. USA 2:8149-8153; Bensen et al. (1995) Plant Cell 7:75-84).
- the latter approach may be accomplished in two ways. First, short segments of the instant nucleic acid fragments may be used in polymerase chain reaction protocols in conjunction with a mutation tag sequence primer on D ⁇ As prepared from a population of plants in which
- Mutator transposons or some other mutation-causing D ⁇ A element has been introduced (see Bensen, supra).
- the amplification of a specific D ⁇ A fragment with these primers indicates the insertion of the mutation tag element in or near the plant gene encoding the oxidosqualene cyclase.
- the instant nucleic acid fragment may be used as a hybridization probe against PCR amplification products generated from the mutation population using the mutation tag sequence primer in conjunction with an arbitrary genomic site primer, such as that for a restriction enzyme site-anchored synthetic adaptor.
- an arbitrary genomic site primer such as that for a restriction enzyme site-anchored synthetic adaptor.
- the present invention is directed to a variety of plant or vegetable protein products.
- a variety of processed vegetable protein products are produced from soybean. These are useful in and as food products including and not limited to human foods as well as animal feed products.
- soy beans and soy nuts such as toasted soy nuts, defatted items such as soybean meal, grits, and flours to more highly processed items such as soy protein concentrates and soy protein isolates.
- soy protein products such as full-fat soy flour
- the oil is not extracted.
- specialty products based on traditional Oriental processes which utilize the entire bean as the starting material, also known as the "whole bean method.”
- additional products include milk (liquid and powder) including and not limited to soy milk, soy sauce, nuts including soy nuts, tofu, natto, miso, tempeh, and yuba.
- soy protein products in human foods include soy milk, applying soy protein concentrates and soy protein isolates in nutritional beverage, emulsified meat and whole muscle meat applications, textured soy protein in meat analogue, and soy protein isolate in infant formula.
- Facilities and methods to produce protein concentrates and isolates from soybeans are available across the world. To the extent that they are retained in these processed soy fractions and the foods prepared from them, the saponin content of the starting beans influences the flavor of the food.
- Examples 1-4 are actual, Examples 5-7 are prophetic. It should be understood that these Examples, while indicating preferred embodiments of the invention, are given by ay of illustration only. From the above discussion and these Examples, one skilled in the art can ascertain the essential characteristics of this invention, and without departing from the spirit and scope thereof, can make various changes and modifications of the invention to adapt it to various usages and conditions. Thus, various modifications of the invention in addition to those shown and described herein will be apparent to those skilled in the art from the foregoing description. Such modifications are also intended to fall within the scope of the appended claims.
- EXAMPLE 1 Composition of cDNA Libraries; Isolation and Sequencing of cDNA Clones cDNA libraries representing mRNAs from various soybean and wheat tissues were prepared. The characteristics of the libraries are described below.
- cDNA libraries may be prepared by any one of many methods available.
- the cDNAs may be introduced into plasmid vectors by first preparing the cDNA libraries in Uni-ZAPTM XR vectors according to the manufacturer's protocol (Stratagene Cloning Systems, La Jolla, CA). The Uni-ZAPTM XR libraries are converted into plasmid libraries according to the protocol provided by Stratagene. Upon conversion, cDNA inserts will be contained in the plasmid vector pBluescript.
- the cDNAs may be introduced directly into precut Bluescript ⁇ SK(+) vectors (Stratagene) using T4 DNA ligase (New England Biolabs), followed by transfection into DH10B cells according to the manufacturer's protocol (GIBCO BRL Products).
- T4 DNA ligase New England Biolabs
- plasmid DNAs are prepared from randomly picked bacterial colonies containing recombinant pBluescript plasmids, or the insert cDNA sequences are amplified via polymerase chain reaction using primers specific for vector sequences flanking the inserted cDNA sequences.
- Amplified insert DNAs or plasmid DNAs are sequenced in dye-primer sequencing reactions to generate partial cDNA sequences (expressed sequence tags or "ESTs"; see Adams et al. (1991) Science 252:1651-1656). The resulting ESTs are analyzed using a Perkin Elmer Model 377 fluorescent sequencer.
- the cDNA sequences obtained in Example 1 were analyzed for similarity to all publicly available DNA sequences contained in the "nr” database using the BLASTN algorithm provided by the National Center for Biotechnology Information (NCBI).
- the DNA sequences were translated in all reading frames and compared for similarity to all publicly available protein sequences contained in the "nr” database using the BLASTX algorithm (Gish and States (1993) Nat. Genet. 3:266-212) provided by the NCBI.
- BLASTX National Center for Biotechnology Information
- the P-value (probability) of observing a match of a cDNA sequence to a sequence contained in the searched databases merely by chance as calculated by BLAST are reported herein as "pLog" values, which represent the negative of the logarithm of the reported P-value. Accordingly, the greater the pLog value, the greater the likelihood that the cDNA sequence and the BLAST "hit" represent homologous proteins.
- a 550 base pair soybean EST having NCBI General Identifier No. 5606831 has been identified as "similar to ⁇ -amyrin synthase," according to the NCBI entrez. Based on Clustal alignment, this sequence is 62.0% identical to SEQ ID NO:l, 62.9% to SEQ ID NO:3, 64.2% to SEQ ID NO:5, and 38.4% to SEQ ID NO:7.
- the longest contiguous stretch of identity is 18 nucleotides. This 18 nucleotide stretch corresponds to nucleotides 2372 through 2390 from sahlc.pk002.n23 and nucleotides 120 through 138 from NCBI General Identifier No. 5606831.
- the sequence of the entire cDNA insert from clone sdp3c.pk020.ol0 is shown in SEQ ID NO:l; the deduced amino acid sequence of this cDNA is shown in SEQ ID NO:2.
- the sequence of the entire cDNA insert from clone src3c.pk024.ml 1 is shown in SEQ ED NO:3; the deduced amino acid sequence of this cDNA is shown in SEQ ID NO:4.
- the sequence of the entire cDNA insert from clone sahlc.pk002.n23 is shown in SEQ ID NO:5; the deduced amino acid sequence of this cDNA is shown in SEQ ID NO:6.
- EXAMPLE 4 Demonstration of Functional Expression of ⁇ -amyrin synthase in Yeast
- the inserts in cDNA clones src3c.pk024.mll and sahlc.pk002.n23 were identified as candidate ⁇ -amyrin synthase genes by a BLAST search against the NCBI database.
- the 5' sequence of these inserts was determined to be related to either of the ⁇ -amyrin synthases from Panax ginseng, the complete coding sequence of which may be found as DDBJ Accession Nos. AB014057 and AB009030 having NCBI General Identifier Nos. 3721856 and 3688600.
- ⁇ -amyrin synthase catalyzes the cyclization of 2,3-oxidosqualene to ⁇ -amyrin.
- the polypeptides encoded by these inserts were evaluated for their ability to catalyze the formation of ⁇ -amyrin.
- Plasmid DNA (200 ng) from cDNA clone sahlc.pk002.n23 was used as template for PCR using primers set forth in SEQ ID NO:10 and SEQ ID NO:ll.
- the 24 nucleotides at the 5' terminus of both primers set forth as SEQ ID NO:9 and SEQ ED NO: 10 are homologous to the modified pRS315 plasmid described below.
- the 22 nucleotides at the 3' terminus of the primer set forth in SEQ ID NO: 9 is derived from the start of transcription of the protein encoded hy clone src3c.pk0024.ml 1.
- the 22 nucleotides at the 3' terminus of the primer set forth in SEQ ID NO: 10 is derived from the start of transcription of the protein encoded by clone sahlc.pk002.n23.
- the sequence of the primer set forth as SEQ ID NO: 11 is homologous to vector sequences.
- Amplification was performed using the GC melt kit (Clontech) with a 1 M final concentration of GC melt reagent. Amplification took place in a Perkin Elmer 9700 thermocycler for 30 cycles as follows: 94°C for 30 seconds, 60°C for 30 seconds, and 72°C for 2 minutes. The amplified insert was then incubated with a modified pRS315 plasmid (NCBI General Identifier No. 984798; Sikorski, R. S. and Hieter, P. (1989) Genetics 122:19-21) that had been digested with Not I and Spe I. Plasmid pRS315 had been previously modified by the insertion of a bidirectional gall/10 promoter between the Xho I and Hind IH sites.
- the plasmid was then transformed into the YPH yeast strain using standard procedures where the insert recombines through gap repair to form the desired transformed yeast strain (Hua, S. B. et al. (1997) Plasmid 55:91-96.).
- the resulting transformed yeast strains were named Yeast Strains ⁇ -amyrin X and ⁇ -amyrin Y.
- Yeast cells were prepared according to a modification of the methods of Pompon et al. (Pompon, D. et al. (1996) Meth. Enz. 272:51-64). Briefly, a yeast colony was grown overnight (to saturation) in SG (-Leucine) medium at 30°C with good aeration. A 1 :50 dilution of this culture was made into 500 mL of YPGE medium with adenine supplementation and allowed to grow at 30°C with good aeration to an of 1.6 (24-30 h). Fifty mL of 20% galactose was added, and the culture was allowed to grow overnight at 30°C.
- the cells were recovered by centrifugation at 5,500 ipm for five minutes in a Sorvall GS-3 rotor.
- the cell pellet was resuspended in 500 L of 0.1 M potassium phosphate buffer (pH 7.0) and then allow to grow at 30°C for another 24 hours.
- the cells were recovered by centrifugation as described above and the presence of ⁇ -amyrin was determined by HPLC/mass spectrometry.
- a chimeric gene comprising a cDNA encoding ⁇ -amyrin synthase in sense orientation with respect to the maize 27 kD zein promoter that is located 5' to the cDNA fragment, and the 10 kD zein 3' end that is located 3' to the cDNA fragment, can be constructed.
- the cDNA fragment of this gene may be generated by polymerase chain reaction (PCR) of the cDNA clone using appropriate ohgonucleotide primers.
- Cloning sites (Nco I or Sma I) can be incorporated into the oligonucleotides to provide proper orientation of the DNA fragment when inserted into the digested vector pML103 as described below.
- Amplification is then performed in a standard PCR reaction.
- the amplified DNA is then digested with restriction enzymes Nco I and Sma I and fractionated on an agarose gel.
- the appropriate band can be isolated from the gel and combined with a 4.9 kb Nco I-Sma I fragment of the plasmid pML103.
- Plasmid pML103 has been deposited under the terms of the Budapest Treaty at ATCC (American Type Culture Collection, 10801 University Boulevard., Manassas, VA 20110-2209), and bears accession number ATCC 97366.
- the DNA segment from pML103 contains a 1.05 kb Sal I-Nco I promoter fragment of the maize 27 kD zein gene and a 0.96 kb Sma I-Sal I fragment from the 3' end of the maize 10 kD zein gene in the vector pGem9Zf(+) (Promega).
- Vector and insert DNA can be ligated at 15°C overnight, essentially as described (Sambrook). The ligated DNA may then be used to transform E. coli XLl-Blue (Epicurian Coli XL-1 BlueTM; Stratagene).
- Bacterial transformants can be screened by restriction enzyme digestion of plasmid DNA and limited nucleotide sequence analysis using the dideoxy chain termination method (SequenaseTM DNA Sequencing Kit; U. S. Biochemical).
- the resulting plasmid construct would comprise a chimeric gene encoding, in the 5' to 3' direction, the maize 27 kD zein promoter, a cDNA encoding ⁇ -amyrin synthase, and the 10 kD zein 3' region.
- the chimeric gene described above can then be introduced into corn cells by the following procedure. Immature corn embryos can be dissected from developing caryopses derived from crosses of the inbred corn lines H99 and LH132.
- the embryos are isolated 10 to 11 days after pollination when they are 1.0 to 1.5 mm long.
- the embryos are then placed with the axis-side facing down and in contact with agarose-solidified N6 medium (Chu et al. (1975) Sci. Sin. Peking 18:659-668).
- the embryos are kept in the dark at 27°C.
- Friable embryogenic callus consisting of undifferentiated masses of cells with somatic proembryoids and embryo ids borne on suspensor structures proliferates from the scutellum of these immature embryos.
- the embryogenic callus isolated from the primary explant can be cultured on N6 medium and sub-cultured on this medium every 2 to 3 weeks.
- the plasmid, p35S/Ac (obtained from Dr. Peter Eckes, Hoechst Ag, Frankfurt, Germany) may be used in transformation experiments in order to provide for a selectable marker.
- This plasmid contains the Pat gene (see European Patent Publication 0 242,236) which encodes phosphinothricin acetyl transferase (PAT).
- PAT phosphinothricin acetyl transferase
- the enzyme PAT confers resistance to herbicidal glutamine synthetase inhibitors such as phosphinothricin.
- the pat gene in p35S/Ac is under the control of the 35S promoter from Cauliflower Mosaic Virus (Odell et al. (1985) Nature 313:810-812) and the 3' region of the nopaline synthase gene from the T-DNA of the Ti plasmid of Agrobacterium tumefaciens.
- the particle bombardment method (Klein et al. (1987) Nature 327:70-73) may be used to transfer genes to the callus culture cells.
- gold particles (1 ⁇ m in diameter) are coated with DNA using the following technique.
- Ten ⁇ g of plasmid DNAs are added to 50 ⁇ L of a suspension of gold particles (60 mg per mL).
- Calcium chloride 50 ⁇ L of a 2.5 M solution
- spermidine free base (20 ⁇ L of a 1.0 M solution) are added to the particles.
- the suspension is vortexed during the addition of these solutions. After 10 minutes, the tubes are briefly centrifuged (5 sec at 15,000 rpm) and the supernatant removed.
- the particles are resuspended in 200 ⁇ L of absolute ethanol, centrifuged again and the supernatant removed. The ethanol rinse is performed again and the particles resuspended in a final volume of 30 ⁇ L of ethanol.
- An aliquot (5 ⁇ L) of the DNA-coated gold particles can be placed in the center of a KaptonTM flying disc (Bio-Rad Labs).
- the particles are then accelerated into the corn tissue with a BiolisticTM PDS-1000/He (Bio-Rad Instruments, Hercules CA), using a helium pressure of 1000 psi, a gap distance of 0.5 cm and a flying distance of 1.0 cm.
- the embryogenic tissue is placed on filter paper over agarose- solidified N6 medium.
- the tissue is arranged as a thin lawn and covered a circular area of about 5 cm in diameter.
- the petri dish containing the tissue can be placed in the chamber of the PDS-1000/He approximately 8 cm from the stopping screen.
- the air in the chamber is then evacuated to a vacuum of 28 inches of Hg.
- the macrocarrier is accelerated with a helium shock wave using a rupture membrane that bursts when the He pressure in the shock tube reaches 1000 psi.
- tissue can be transferred to N6 medium that contains glufosinate (2 mg per liter) and lacks casein or proline. The tissue continues to grow slowly on this medium. After an additional 2 weeks the tissue can be transferred to fresh N6 medium containing gluphosinate. After 6 weeks, areas of about 1 cm in diameter of actively growing callus can be identified on some of the plates containing the glufosinate- supplemented medium. These calluses may continue to grow when sub-cultured on the selective medium.
- Plants can be regenerated from the transgenic callus by first transferring clusters of tissue to N6 medium supplemented with 0.2 mg per liter of 2,4-D. After two weeks the tissue can be transferred to regeneration medium (Fromm et al., (1990) Bio/Technology 8:833-839).
- a seed-specific expression cassette composed of the promoter and transcription terminator from the gene encoding the ⁇ subumt of the seed storage protein phaseolin from the bean Phaseolus vulgaris (Doyle et al. (1986) J. Biol. Chem. 261 :9228-9238) can be used for expression of the instant enzymes ⁇ -amyrin synthase in transformed soybean.
- the phaseolin cassette includes about 500 nucleotides upstream (5') from the translation initiation codon and about 1650 nucleotides downstream (3') from the translation stop codon of phaseolin.
- Nco I which includes the ATG translation initiation codon
- Sma I which includes the ATG translation initiation codon
- Kpn I The entire cassette is flanked by Hind m sites.
- the cDNA fragment of this gene maybe generated by polymerase chain reaction (PCR) of the cDNA clone using appropriate ohgonucleotide primers. Cloning sites can be incorporated into the oligonucleotides to provide proper orientation of the DNA fragment when inserted into the expression vector. Amplification is then performed as described above, and the isolated fragment is inserted into a pUC18 vector carrying the seed expression cassette.
- PCR polymerase chain reaction
- Soybean embryos may then be transformed with the expression vector comprising sequences encoding ⁇ -amyrin synthase.
- somatic embryos cotyledons, 3-5 mm in length dissected from surface sterilized, immature seeds of the soybean cultivar A2872, can be cultured in the light or dark at 26°C on an appropriate agar medium for 6-10 weeks. Somatic embryos which produce secondary embryos are then excised and placed into a suitable liquid medium. After repeated selection for clusters of somatic embryos which multiplied as early, globular staged embryos, the suspensions are maintained as described below.
- Soybean embryogenic suspension cultures can maintained in 35 mL liquid media on a rotary shaker, 150 rpm, at 26°C with florescent lights on a 16:8 hour day/night schedule. Cultures are subcultured every two weeks by inoculating approximately 35 mg of tissue into 35 mL of liquid medium.
- Soybean embryogenic suspension cultures may then be transformed by the method of particle gun bombardment (Kline et al. (1987) Nature (London) 327:10, U.S. Patent No. 4,945,050).
- a DuPont BiolisticTM PDS1000/HE instrument helium retrofit
- a selectable marker gene which can be used to facilitate soybean transformation is a chimeric gene composed of the 35S promoter from Cauliflower Mosaic Virus (Odell et al. (1985) Nature 575:810-812), the hygromycin phosphotransferase gene from plasmid pJR225 (from E. coli; Gritz et al.(1983) Gene 25:179-188) and the 3' region of the nopaline synthase gene from the T-DNA of the Ti plasmid of Agrobacterium tumefaciens.
- the seed expression cassette comprising the phaseolin 5' region, the fragment encoding the enzyme involved in squalene metabolism and the phaseolin 3' region can be isolated as a restriction fragment. This fragment can then be inserted into a unique restriction site of the vector carrying the marker gene.
- Approximately 300-400 mg of a two-week-old suspension culture is placed in an empty 60x 15 mm petri dish and the residual liquid removed from the tissue with a pipette.
- approximately 5-10 plates of tissue are normally bombarded.
- Membrane rupture pressure is set at 1100 psi and the chamber is evacuated to a vacuum of 28 inches mercury.
- the tissue is placed approximately 3.5 inches away from the retaining screen and bombarded three times. Following bombardment, the tissue can be divided in half and placed back into liquid and cultured as described above.
- the liquid media may be exchanged with fresh media, and eleven to twelve days post bombardment with fresh media containing 50 mg/mL hygromycin. This selective media can be refreshed weekly.
- green, transformed tissue may be observed growing from untransformed, necrotic embryogenic clusters. Isolated green tissue is removed and inoculated into individual flasks to generate new, clonally propagated, transformed embryogenic suspension cultures. Each new line may be treated as an independent transformation event. These suspensions can then be subcultured and maintained as clusters of immature embryos or regenerated into whole plants by maturation and germination of individual somatic embryos.
- EXAMPLE 7 Expression of Chimeric Genes in Microbial Cells
- the cDNAs encoding the instant enzyme ⁇ -amyrin synthase can be inserted into the T7 E. coli expression vector pBT430.
- This vector is a derivative of pET-3a (Rosenberg et al. (1987) Gene 56: 125-135) which employs the bacteriophage T7 RNA polymerase/T7 promoter system.
- Plasmid pBT430 may be constructed by first destroying the EcoR I and Hind DI sites in pET-3a at their original positions. An ohgonucleotide adaptor containing EcoR I and Hind HI sites may be inserted at the BamH I site of pET-3a.
- Plasmid DNA containing a cDNA may be appropriately digested to release a nucleic acid fragment encoding the protein. This fragment may then be purified on a 1% NuSieve GTGTM low melting agarose gel (FMC). Buffer and agarose contain 10 ⁇ g/ml ethidium bromide for visualization of the DNA fragment. The fragment can then be purified from the agarose gel by digestion with GELaseTM (Epicentre Technologies) according to the manufacturer's instructions, ethanol precipitated, dried and resuspended in 20 ⁇ L of water. Appropriate ohgonucleotide adapters may be ligated to the fragment using T4 DNA ligase (New England Biolabs, Beverly, MA).
- the fragment containing the ligated adapters can be purified from the excess adapters using low melting agarose as described above.
- the vector pBT430 is digested, dephosphorylated with alkaline phosphatase (NEB) and deproteinized with phenol/chloroform as described above.
- the prepared vector ⁇ BT430 and fragment can then be ligated at 16°C for 15 hours followed by transformation into DH5 electrocompetent cells (GIBCO BRL).
- Transformants can be selected on agar plates containing LB media and 100 ⁇ g/mL ampicillin. Transformants containing the gene encoding the enzyme involved in squalene metabolism may then be screened for the correct orientation with respect to the T7 promoter by restriction enzyme analysis.
- a plasmid clone with the cDNA insert in the correct orientation relative to the T7 promoter can be transformed into E. coli strain BL21(DE3) (Studier et al. (1986) J. Mol. Biol. 189: 13-130). Cultures are grown in LB medium containing ampicillin (100 mg/L) at 25°C. At an optical density at 600 nm of approximately 1, IPTG (isopropylthio- ⁇ -galactoside, the inducer) can be added to a final concentration of 0.4 mM and incubation can be continued for 3 h at 25°.
- IPTG isopropylthio- ⁇ -galactoside, the inducer
- Cells are then harvested by centrifugation and re-suspended in 50 ⁇ L of 50 mM Tris-HCl at pH 8.0 containing 0.1 mM DTT and 0.2 mM phenyl methylsulfonyl fluoride.
- a small amount of 1 mm glass beads can be added and the mixture sonicated 3 times for about 5 seconds each time with a microprobe sonicator.
- the mixture is centrifuged and the protein concentration of the supernatant determined.
- One ⁇ g of protein from the soluble fraction of the culture can be separated by SDS-polyacrylamide gel electrophoresis. Gels can be observed for protein bands migrating at the expected molecular weight.
Abstract
Description
Claims
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/221,074 US7135624B2 (en) | 2001-03-09 | 2001-03-09 | Enzymes involved in triterpene synthesis |
AU2001247348A AU2001247348A1 (en) | 2000-03-09 | 2001-03-09 | Nucleic acids that code for oxidosqualene cyclases |
CA002401708A CA2401708A1 (en) | 2000-03-09 | 2001-03-09 | Enzymes involved in triterpene synthesis |
EP01920274A EP1352069A2 (en) | 2000-03-09 | 2001-03-09 | Nucleic acids that code for oxidosqualene cyclases |
BR0109258-8A BR0109258A (en) | 2000-03-09 | 2001-03-09 | Enzymes involved in triterpene synthesis |
US11/500,769 US20060277636A1 (en) | 2000-03-09 | 2006-08-08 | Enzymes involved in triterpene synthesis |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US18805400P | 2000-03-09 | 2000-03-09 | |
US60/188,054 | 2000-03-09 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/500,769 Division US20060277636A1 (en) | 2000-03-09 | 2006-08-08 | Enzymes involved in triterpene synthesis |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2001066773A2 true WO2001066773A2 (en) | 2001-09-13 |
WO2001066773A3 WO2001066773A3 (en) | 2003-08-07 |
Family
ID=22691610
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2001/007611 WO2001066773A2 (en) | 2000-03-09 | 2001-03-09 | Nucleic acids that code for oxidosqualene cyclases |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1352069A2 (en) |
AU (1) | AU2001247348A1 (en) |
BR (1) | BR0109258A (en) |
CA (1) | CA2401708A1 (en) |
WO (1) | WO2001066773A2 (en) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003095615A2 (en) * | 2002-05-09 | 2003-11-20 | E.I. Du Pont De Nemours And Company | Transgenic plants with a suppressed triterpene level |
EP1504122A2 (en) * | 2002-05-04 | 2005-02-09 | The Samuel Roberts Noble Foundation, Inc. | Methods of identifying genes for the manipulation of triterpene saponins |
WO2007056347A1 (en) * | 2005-11-07 | 2007-05-18 | E. I. Du Pont De Nemours And Company | Compositions with increased phytosterol levels obtained from plants with decreased triterpene saponin levels |
EP2145959A2 (en) * | 2004-02-25 | 2010-01-20 | Meiji Seika Kaisha, Ltd. | Triterpene Hydroxylase |
CN109182244A (en) * | 2018-08-01 | 2019-01-11 | 天津大学 | A method of improving Bacillus natto biomass under the high temperature conditions |
EP3650542A1 (en) * | 2018-11-08 | 2020-05-13 | Fraunhofer Gesellschaft zur Förderung der Angewand | Method to obtain low triterpene/triterpenoid-containing natural rubber latex |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1995030009A2 (en) * | 1994-04-29 | 1995-11-09 | Gatsby Charitable Foundation | Identification, production and use of saponin glyclosyl hydrolases |
-
2001
- 2001-03-09 AU AU2001247348A patent/AU2001247348A1/en not_active Abandoned
- 2001-03-09 CA CA002401708A patent/CA2401708A1/en not_active Abandoned
- 2001-03-09 WO PCT/US2001/007611 patent/WO2001066773A2/en not_active Application Discontinuation
- 2001-03-09 BR BR0109258-8A patent/BR0109258A/en not_active IP Right Cessation
- 2001-03-09 EP EP01920274A patent/EP1352069A2/en not_active Withdrawn
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1995030009A2 (en) * | 1994-04-29 | 1995-11-09 | Gatsby Charitable Foundation | Identification, production and use of saponin glyclosyl hydrolases |
Non-Patent Citations (10)
Title |
---|
BACH T J ET AL.: "Cloning of cDNAs or genes encoding enzymes of sterol biosynthesis from plants and other eukaryotes: heterologous expression and complementation analysis of mutations for functional characterization." PROGRESS IN LIPID RESEARCH, vol. 36, no. 2/3, 1997, pages 197-226, XP001031154 * |
DATABASE EM_PL [Online] EMBL; ID AB009030, ID AB009030, 5 October 1998 (1998-10-05) KUSHIRO T: "Panax ginseng OSCPNY1 mRNA for beta-Amyrin Synthase, complete cds" XP002191889 cited in the application -& KUSHIRO T ET AL.: "beta-Amyrin synthase: Cloning of oxidosqualene cyclase that catalyzes the formation of the most popular triterpene among higher plants." EUROPEAN JOURNAL OF BIOCHEMISTRY, vol. 256, no. 1, August 1998 (1998-08), pages 238-244, XP002191879 cited in the application * |
DATABASE SCISEARCH [Online] STN; AN 94:267952, 1994 TSUKAMOTO C ET AL.: "Genetic improvement of saponin components in soybean" XP002193758 & TSUKAMOTO C ET AL.: "Genetic improvement of saponin components in soybean" ACS SYMPOSIUM SERIES, vol. 546, 1994, pages 372-379, * |
HAYASHI H ET AL.: "Molecular cloning and characterization of a cDNA for Glycyrrhiza glabra cycloartenol synthase." BIOLOGICAL & PHARMACEUTICAL BULLETIN, vol. 23, no. 2, February 2000 (2000-02), pages 231-234, XP002191881 ISSN: 0918-6158 * |
KIKUCHI A ET AL.: "Inheritance and characterization of a null allele for group A acetyl saponins found in a mutant soybean ( Glycine max (L.) Merrill." BREEDING SCIENCE, vol. 49, no. 3, 1999, pages 167-171, XP008001169 * |
LUSAS E W ET AL.: "Soy protein products: Processing and use." JOURNAL OF NUTRITION, vol. 125, no. 3 SUPPL., 1995, pages 573S-580S, XP001064997 First International Symposium on the Role of Soy in Preventing and Treating Chronic Disease;Mesa, Arizona, USA; February 20-23, 1994 ISSN: 0022-3166 * |
SHIBUYA M ET AL.: "Two branches of the lupeol synthase gene in the molecular evolution of plant oxidosqualene cyclases." EUROPEAN JOURNAL OF BIOCHEMISTRY, vol. 266, no. 1, November 1999 (1999-11), pages 302-307, XP002191880 ISSN: 0014-2956 * |
TSUKAMOTO C ET AL.: "Factors affecting isoflavone content in soybean seeds: changes in isoflavones, saponins, and composition of fatty acids at different temperatures during seed development" JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, vol. 43, no. 5, 1995, pages 1184-1192, XP002193757 ISSN: 0021-8561 * |
TSUKAMOTO C ET AL.: "Genetic and chemical polymorphisms of saponins in soybean seed." PHYTOCHEMISTRY (OXFORD), vol. 34, no. 5, 1993, pages 1351-1356, XP001066501 ISSN: 0031-9422 * |
YOSHIKI Y ET AL.: "Relationship between chemical structures and biological activities of triterpenoid saponins from soybean." BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY, vol. 62, no. 12, December 1998 (1998-12), pages 2291-2299, XP002191885 ISSN: 0916-8451 * |
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1504122A2 (en) * | 2002-05-04 | 2005-02-09 | The Samuel Roberts Noble Foundation, Inc. | Methods of identifying genes for the manipulation of triterpene saponins |
EP1504122A4 (en) * | 2002-05-04 | 2006-04-05 | Samuel Roberts Noble Found Inc | Methods of identifying genes for the manipulation of triterpene saponins |
WO2003095615A2 (en) * | 2002-05-09 | 2003-11-20 | E.I. Du Pont De Nemours And Company | Transgenic plants with a suppressed triterpene level |
WO2003095615A3 (en) * | 2002-05-09 | 2004-09-16 | Du Pont | Transgenic plants with a suppressed triterpene level |
EP2145959A2 (en) * | 2004-02-25 | 2010-01-20 | Meiji Seika Kaisha, Ltd. | Triterpene Hydroxylase |
EP2145959A3 (en) * | 2004-02-25 | 2010-08-25 | Meiji Seika Kaisha, Ltd. | Triterpene Hydroxylase |
WO2007056347A1 (en) * | 2005-11-07 | 2007-05-18 | E. I. Du Pont De Nemours And Company | Compositions with increased phytosterol levels obtained from plants with decreased triterpene saponin levels |
US7750210B2 (en) | 2005-11-07 | 2010-07-06 | E. I. Du Pont De Nemours And Company | Compositions with increased phytosterol levels obtained from plants with decreased triterpene saponin levels |
CN109182244A (en) * | 2018-08-01 | 2019-01-11 | 天津大学 | A method of improving Bacillus natto biomass under the high temperature conditions |
EP3650542A1 (en) * | 2018-11-08 | 2020-05-13 | Fraunhofer Gesellschaft zur Förderung der Angewand | Method to obtain low triterpene/triterpenoid-containing natural rubber latex |
WO2020094838A1 (en) * | 2018-11-08 | 2020-05-14 | Fraunhofer-Gesellschaft Zur Foerderung Der Angewandten Forschung E.V. | Method to obtain low triterpene/triterpenoid-containing natural rubber latex |
Also Published As
Publication number | Publication date |
---|---|
CA2401708A1 (en) | 2001-09-13 |
EP1352069A2 (en) | 2003-10-15 |
WO2001066773A3 (en) | 2003-08-07 |
BR0109258A (en) | 2003-06-03 |
AU2001247348A1 (en) | 2001-09-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6617493B1 (en) | Nucleotide sequence encoding soybean vestitone reductase | |
US20060277636A1 (en) | Enzymes involved in triterpene synthesis | |
US8143479B2 (en) | Plastidic phosphoglucomutase genes | |
EP1352069A2 (en) | Nucleic acids that code for oxidosqualene cyclases | |
US6864077B1 (en) | Membrane-bound desaturases | |
US7608443B2 (en) | Lysophosphatidic acid acetyltransferases | |
US7572951B2 (en) | Plant viral movement protein genes | |
US20040121439A1 (en) | Enzymes involved in squalene metabolism | |
WO2000060087A2 (en) | Cyclin dependent kinase inhibitor genes from plants | |
EP1109910A2 (en) | Thioredoxin h homologs | |
US20060156441A1 (en) | Aspartate kinase | |
US7271318B2 (en) | Plant genes encoding pantothenate synthetase | |
US6627798B2 (en) | Aromatic amino acid biosynthetic enzymes | |
WO2000037652A2 (en) | Flavonoid biosynthetic enzymes | |
US6184036B1 (en) | Ornithine biosynthesis enzymes | |
US6897356B1 (en) | Thioredoxin H homologs | |
EP1151084A2 (en) | Plant polyphenol oxidase homologs | |
EP1144649A2 (en) | Lysophosphatidic acid acetyltransferases | |
WO2000024915A2 (en) | Plant raffinose synthase homologs | |
WO2000032790A2 (en) | Membrane-bound desaturases | |
WO2000078965A2 (en) | Plant auxin proteins | |
US20050229268A1 (en) | Plant carbon catabolite repression proteins | |
WO2000036116A2 (en) | Plant catabolite repression genes |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2401708 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 10221074 Country of ref document: US |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2001920274 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2001247348 Country of ref document: AU |
|
WWP | Wipo information: published in national office |
Ref document number: 2001920274 Country of ref document: EP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 2001920274 Country of ref document: EP |
|
NENP | Non-entry into the national phase in: |
Ref country code: JP |